Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3021901	cb-hbo2sat	% (—)	7244	20451	100.00%	Distribution not available
3021901	cb-hbo2sat	— (—)	653	804	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

ILD medications

2107

4298

2.70

323.01

3.8

2.3

—

Later onset COPD, excluding more controls

606

760

6.50

322.40

3.6

2.2

—

Type 2 diabetes

1805

3715

2.89

319.42

2.9

2.5

—

COPD related to multimorbidity

1115

2663

3.69

318.09

3.9

2.6

—

Diabetes, insulin treatment (Kela reimbursement)

1939

4334

2.76

317.66

3.0

2.7

—

Viral pneumonia

450

609

7.91

316.30

4.8

2.2

—

COPD, hospital admission 2, with asthma infections

966

2144

4.05

314.33

4.2

2.6

—

Covid-19 confirmed case

1298

2633

5.23

307.65

3.9

2.6

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2167

2907

4.65

307.65

3.7

2.1

—

Other respiratory disorders and diseases

740

1577

5.00

307.65

5.3

2.6

—

Pneumonia, organism unspecified

2367

3732

4.60

307.65

3.7

2.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

2145

4237

2.89

307.65

3.8

2.3

—

Acute tubulo-interstitial nephritis

1335

3181

3.72

307.65

3.7

2.3

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1576

4378

3.40

307.65

3.4

2.7

—

Extracorporeal dialysis

386

398

11.41

307.65

6.1

2.8

—

Viral Sepsis

710

1112

6.81

307.65

4.6

2.2

—

Other chronic obstructive pulmonary disease, including avohilmo

1341

3467

3.31

307.65

3.7

2.6

—

Oral corticosteroids

2089

4588

2.75

307.65

3.3

2.5

—

Insulin, fast-acting

1039

2495

4.35

307.65

3.7

2.8

—

Other heart diseases

861

951

6.06

307.65

3.6

2.2

—

Insulin medication

1572

3552

3.85

307.65

3.4

2.8

—

Asthma (only as main-diagnosis), excluding more controls

1177

1462

4.70

307.65

2.9

2.0

—

Insulin, fast-acting or short human

1045

2674

4.07

307.65

3.7

2.8

—

Implicit bacterial Sepsis

1387

2337

5.55

307.65

4.2

2.2

—

COPD

1260

2713

3.96

307.65

3.7

2.6

—

Heart failure and coronary heart disease

1244

2219

4.16

307.65

3.9

2.6

—

Pneumonias (Asthma/COPD co-morbidities)

2450

4000

4.24

307.65

3.7

2.2

—

Metabolic disorders

1937

3859

3.13

307.65

3.4

2.6

—

Septicaemia

1325

2642

4.92

307.65

4.3

2.5

—

COPD/asthma/ILD related infections

1782

2908

3.12

307.65

3.3

2.1

—

COPD, early/later onset

1228

3017

3.57

307.65

3.8

2.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1855

4291

2.87

307.65

3.7

2.5

—

Insulin, intermediate and long-acting

1438

4110

3.52

307.65

3.3

2.8

—

Cardiovascular diseases (excluding rheumatic etc)

996

1224

4.77

307.65

3.5

2.1

—

Implicit viral Sepsis

710

1109

6.83

307.65

4.6

2.2

—

Heart failure, strict

1717

2840

4.46

307.65

3.8

2.5

—

Influenza and pneumonia

2454

3929

4.08

307.65

3.7

2.2

—

Other disorders of fluid, electrolyte and acid-base balance

1033

1901

5.47

307.65

3.7

2.6

—

Persons encountering health services in other circumstances

981

2242

4.51

307.65

2.9

2.6

—

Heart failure and antihypertensive medication

831

619

9.31

307.65

4.0

2.3

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2131

4146

2.85

307.65

3.3

2.6

—

Implicit viral Sepsis

859

1682

5.36

307.65

4.4

2.2

—

Heart failure, not strict

2098

2901

5.12

307.65

3.9

2.2

—

Codes for special purposes

1465

3687

4.12

307.65

3.8

2.6

—

Provisional assignment of new diseases of uncertain etiology

1462

3683

4.12

307.65

3.8

2.6

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2379

4100

4.08

307.65

3.7

2.3

—

Hypertensive diseases (excluding secondary)

966

905

6.36

307.65

3.6

2.0

—

Implicit bacterial Sepsis

1466

2465

5.41

307.65

4.2

2.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2161

3607

4.26

307.65

3.6

2.2

—

COPD, hospital admissions

1229

3001

3.60

307.65

3.8

2.6

—

Bacterial Sepsis

1531

2542

5.42

307.65

4.3

2.2

—

Heart failure,strict

1584

2172

5.40

307.65

3.8

2.3

—

Early onset COPD, excluding more controls

548

748

7.68

307.65

4.0

2.4

—

Persons encountering health services for specific procedures and health care

2210

4218

3.21

307.65

3.6

2.4

—

Persons encountering health services in other circumstances, wide

2301

4182

2.89

307.65

3.2

2.6

—

Explicit Sepsis

1357

2572

5.16

307.65

4.2

2.2

—

Transplanted organ and tissue status

443

480

10.22

307.65

7.0

2.6

—

Acute renal failure

895

1330

7.29

307.65

4.5

2.4

—

Hypertension

1393

2178

3.68

307.65

3.4

2.4

—

All chronic kidney diseases

2169

2623

7.21

307.65

4.1

2.4

—

Asthma, unspecified (mode), excluding more controls

1119

1350

6.39

307.65

3.1

2.0

—

Kidney transplant status

333

282

13.91

307.65

7.5

2.9

—

Bacterial infection, other or unspecified

1443

3065

4.25

307.65

3.7

2.5

—

Dyspnoea

2101

4671

3.42

307.65

3.2

2.7

—

All pneumoniae

2456

4021

4.20

307.65

3.7

2.3

—

Care involving dialysis

518

408

14.89

307.65

6.6

2.4

—

Other bacterial diseases

2326

4180

3.85

307.65

3.7

2.4

—

Other septicaemia

1206

2425

5.03

307.65

4.2

2.6

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1822

3754

2.98

307.65

3.0

2.7

—

Anaemias

549

209

17.80

307.65

4.5

2.5

—

Asthma, excluding more controls

1281

1462

4.66

307.65

2.9

2.0

—

Other bacterial diseases

2302

4109

3.65

307.65

3.6

2.4

—

All kidney diseases

2604

3905

4.71

307.65

3.7

2.2

—

Fever of other and unknown origin

1305

2963

4.04

307.65

3.6

2.7

—

Asthma (only as main-diagnosis)

1224

1771

4.08

307.65

2.9

2.1

—

Malaise and fatigue

1139

2543

3.71

307.65

2.8

2.7

—

Glomerular diseases

712

1238

6.21

307.65

5.1

2.8

—

Asthma

1355

1771

4.09

307.65

2.9

2.1

—

Hypertensive diseases

1393

2180

3.68

307.65

3.4

2.5

—

Chronic kidney disease

1676

2060

8.86

307.65

4.5

2.5

—

Other diseases of pleura

1334

3149

3.88

307.65

4.3

2.6

—

Sleep apnoea

1861

4301

2.86

307.65

2.8

—

Bacterial infection, other or unspecified

1566

3194

4.31

307.65

3.6

2.5

—

Hypertension, essential

1399

2106

3.84

307.65

3.0

2.4

—

Dialysis, with operation codes

652

681

10.75

307.65

6.5

2.6

—

Asthma, unspecified (mode)

1160

1642

5.48

307.65

3.1

2.1

—

Glomerular disorders in diseases classified elsewhere

518

768

7.42

307.65

4.9

2.7

—

Renal failure

2155

2809

7.37

307.65

4.3

2.5

—

Respiratory insufficiency

455

316

16.22

307.65

6.2

2.2

—

Other chronic obstructive pulmonary disease

1215

2628

3.97

307.65

3.8

2.6

—

Implicit Sepsis

2137

3496

4.79

307.65

3.8

2.2

—

All-cause Heart Failure

1689

2799

4.46

307.65

3.7

2.5

—

L04AD Calcineurin inhibitors

452

584

8.48

307.65

7.0

2.7

—

Nephropathy related operations

640

819

8.80

307.65

6.7

2.7

—

Renal tubulo-interstitial diseases

2633

3832

5.33

307.65

3.9

2.3

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2202

4717

3.30

307.65

3.5

2.6

—

Other diseases of the respiratory system

740

1577

5.00

307.65

5.3

2.6

—

Abnormalities of breathing

1922

3120

3.66

307.65

2.9

2.7

—

COPD (mode)

960

1038

7.66

307.65

3.9

2.3

—

Diabetes mellitus

1908

3910

2.91

307.65

2.9

2.7

—

First line medication for Crohn's disease

2046

4062

2.77

307.65

3.7

2.3

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2146

3634

4.30

307.65

3.8

2.2

—

Secondary hypertension

358

199

19.57

307.65

5.2

2.1

—

Implicit Sepsis

2161

3640

4.49

307.65

3.8

2.2

—

Type 2 diabetes, wide definition

1801

3319

3.57

307.65

3.2

2.5

—

2167

2907

4.65

307.65

3.7

2.1

—

COPD/asthma related infections

1782

2908

3.12

307.65

3.3

2.1

—

Diabetes, varying definitions

1888

3926

2.87

307.65

2.9

2.7

—

Non-ischemic cardiomyopathy

784

1412

4.66

300.69

3.5

2.5

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

498

453

7.87

299.23

4.0

2.2

—

Dialysis

263

188

16.67

295.33

7.7

2.8

—

Other medical care

1040

2688

3.59

293.22

3.5

2.5

—

General symptoms and signs

1852

3383

2.79

292.45

2.9

2.6

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

860

1844

4.19

291.98

4.3

2.6

—

Asthma (mode)

1194

1790

3.63

291.83

2.7

2.1

—

Sleep apnoea, including avohilmo

1861

4390

2.68

290.93

2.7

2.8

—

Heart failure and bmi 25plus

912

1531

4.20

288.38

3.9

2.4

—

Cerebrovascular diseases (FINNGEN)

552

620

6.47

285.87

3.3

2.1

—

Aplastic and other anaemias

1174

3478

3.26

285.58

3.8

2.8

—

Other heart diseases, wide

1542

3286

2.92

281.98

3.3

2.5

—

Inflammatory bowel disease treatment related agents

2078

4710

2.51

278.29

3.6

2.5

—

Presence of other functional implants

1300

2942

3.15

278.09

3.0

2.7

—

Erysipelas

1362

3573

2.97

273.25

3.4

2.4

—

Atrial fibrillation and flutter

547

566

6.43

270.53

3.5

2.1

—

Diabetes medication

1841

4288

2.59

267.25

3.0

2.7

—

Obesity related asthma

815

2167

3.90

266.00

3.1

2.8

—

Cardiac arrhythmias

889

1474

3.99

265.09

3.1

2.2

—

Endocrine, nutritional and metabolic diseases

1238

1897

3.36

265.06

3.1

2.4

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

346

232

11.18

264.93

4.5

2.4

—

Other pulmonary diagnosis

1204

1787

3.43

264.66

3.0

2.1

—

Diabetic nephropathy, excluding more controls

565

896

5.61

262.00

4.2

2.5

—

ILD medications: immunosuppressive drugs

1171

3620

3.07

261.37

4.6

2.3

—

Obesity due to excess calories

961

2882

3.43

260.59

3.1

2.7

—

Cardiovascular diseases

866

1108

4.27

260.47

3.5

2.1

—

Unspecified kidney failure

408

625

7.09

257.20

4.7

2.5

—

COPD, hospital admissions 1, only main diagnosis

957

2435

3.51

254.34

4.1

2.6

—

Asthma, hospital admission 2, infections

1239

4281

2.90

252.57

3.4

2.8

—

Asthma-related infections

1239

4281

2.90

252.57

3.4

2.8

—

Chronic lower respiratory diseases

2110

4769

2.39

252.54

3.1

2.7

—

Infections, IBD-co-morbidities

365

292

9.25

250.84

4.1

2.6

—

Any reimbursement code in KELA

762

819

4.73

249.28

3.2

1.7

—

Other and unspecified anaemias

1060

3290

3.18

248.89

3.7

2.7

—

Asthma-related pneumonia

917

2751

3.44

248.53

3.8

2.9

—

Excluding asthma or asthma-COPD overlap

1173

1787

3.34

248.27

3.0

2.1

—

Other nutritional deficiencies

1234

4106

2.89

248.27

3.2

2.7

—

Other anaemias

1064

3305

3.16

248.23

3.7

2.7

—

Asthma-related pneumonia or sepsis

917

2754

3.44

248.06

3.8

2.9

—

Asthma, hospital admissions 3, pneumonia

917

2754

3.44

248.06

3.8

2.9

—

Type 1 diabetes, wide definition, subgroup 1

521

1033

5.24

247.64

3.5

3.0

—

COPD differential diagnosis

1172

1790

3.33

247.14

3.0

2.1

—

ILD differential diagnosis

1170

1790

3.32

246.08

3.0

2.1

—

Hypertensive heart and/or renal disease

636

1030

4.79

245.84

3.7

2.6

—

ILD, hospital admission 2, with pulmonary infections

348

471

7.96

245.06

4.9

2.2

—

L04AA Selective immunosuppressants

583

1309

4.66

239.54

5.7

2.6

—

Erysipelas

1100

3278

3.04

238.02

3.4

2.5

—

Obesity and other hyperalimentation

1166

3956

2.90

237.43

3.2

2.7

—

Obesity

1158

3927

2.91

236.70

3.2

2.7

—

Type 1 diabetes

592

1353

4.53

236.50

3.6

3.0

—

Other acute lower respiratory infections

1149

3861

2.91

233.28

3.9

2.7

—

Intracranial trauma

967

2073

3.34

230.29

2.8

—

Type 1 diabetes, wide definition

530

1138

4.83

229.13

3.5

2.9

—

Bleeding

1599

4642

2.50

226.38

3.4

2.8

—

Ischemic heart diseases

1458

3334

2.68

226.23

3.4

2.6

—

Atrial fibrillation and flutter with reimbursement

455

6.54

226.08

3.3

2.1

—

Type 2 diabetes, definitions combined

1569

3631

2.58

225.54

2.8

2.5

—

Type 2 diabetes, strict (exclude DM1)

1576

3671

2.56

223.67

2.8

2.5

—

Hard cardiovascular diseases

1431

3242

2.68

222.38

3.4

2.6

—

Acute bronchitis

936

2979

3.17

221.98

4.1

2.7

—

ILD, hospital admissions 3, with pneumonia sepsis

325

460

7.67

220.46

5.1

2.3

—

Oxycodone

871

2450

3.31

217.60

3.4

2.7

—

All influenza

555

1297

4.43

215.82

4.3

2.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

592

801

4.75

215.41

3.3

1.9

—

Hypo-osmolality and hyponatraemia

491

1053

4.87

212.04

3.3

2.6

—

Bronchitis

1862

5207

2.29

211.42

3.5

2.5

—

Percutaneous Coronary Intervention

1378

3251

2.65

210.79

3.5

2.6

—

Type 2 diabetes, definitions combined, including avohilmo

1539

3615

2.52

210.67

2.8

2.6

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1138

3323

2.81

208.49

3.1

2.8

—

Coronary revascularization (ANGIO or CABG)

1372

3251

2.63

207.55

3.5

2.6

—

Diabetic maculopathy, excluding more controls

350

569

6.55

207.31

3.6

2.7

—

Other CVD (FINNGEN)

278

233

9.69

205.27

3.1

2.1

—

Viral pneumonia (unknown virus, not influenza)

287

387

8.11

203.56

5.2

2.6

—

Hyperlipidaemia, other/unspecified

853

2524

3.21

202.82

3.2

2.6

—

Other dialysis

206

184

13.48

202.73

8.4

3.3

—

Antihypertensive medication - note that there are other indications

839

1255

3.59

202.08

3.7

2.1

—

Concussion

815

2061

3.28

197.93

2.6

2.8

—

Symptoms and signs involving the circulatory and respiratory systems

1538

3130

2.49

197.80

2.8

2.7

—

Certain infectious and parasitic diseases

1518

3075

2.51

196.92

3.3

2.3

—

Any death

1219

3351

2.67

196.62

3.5

2.6

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1289

4669

2.52

196.37

3.4

2.8

—

STROKE

868

1855

3.24

195.26

3.0

2.4

—

Pain in throat and chest

1305

3037

2.62

195.20

2.5

2.7

—

Asthma (diagnoses ohter than nonallergic)

1547

5605

2.33

195.12

3.0

2.8

—

Major coronary heart disease event

1456

3611

2.48

194.32

3.5

2.6

—

COPD-related respiratory insufficiency

406

816

5.33

192.16

5.6

2.5

—

Hyperkalaemia

264

347

8.43

191.97

4.7

2.6

—

Disorders of lipoprotein metabolism and other lipidaemias

1390

3498

2.50

191.12

3.0

2.6

—

Early onset COPD

548

1394

4.10

191.06

4.0

2.6

—

Emergency coronary revascularization (for ACS)

1507

3873

2.41

189.76

3.4

2.7

—

Intestinal infectious diseases

1644

5620

2.25

188.91

3.5

2.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

1287

4793

2.46

187.04

3.8

2.6

—

851

2864

3.02

186.99

3.4

2.9

—

Valvular heart disease excluding rheumatic fever

842

1955

3.18

186.50

3.4

2.5

—

Nutritional anaemias

1037

3767

2.72

186.23

3.4

2.8

—

Iron deficiency anaemia

907

3156

2.91

185.51

3.5

2.7

—

Other (not insulin) diabetes medications

1568

4047

2.33

183.66

2.8

2.6

—

Non-rheumatic valve diseases

831

1937

3.17

182.64

3.3

2.4

—

Nausea and vomiting

611

1689

3.65

181.60

4.1

2.8

—

Parasetamol

1131

2080

2.79

180.80

2.8

2.5

—

Hypothyroidism (congenital or acquired)

312

209

8.56

179.59

2.9

2.2

—

Tramadol

1305

3261

2.50

178.56

3.1

2.6

—

1829

4388

2.18

176.75

3.4

2.4

—

Pulmonary heart disease, diseases of pulmonary circulation

743

2430

3.16

175.37

3.4

2.7

—

Coronary atherosclerosis

1141

2789

2.64

175.21

3.3

2.6

—

Hypothyroidism and >3 levothyroxin purchases

302

209

8.29

170.26

2.7

2.2

—

Hypothyroidism, levothyroxine purchases

302

209

8.29

170.26

2.7

2.2

—

Sleep disorders (combined)

1810

4472

2.15

169.97

2.7

2.8

—

Disorders resulting from impaired renal tubular function

199

217

10.58

169.30

6.9

3.0

—

Episodal and paroxysmal disorders

1719

4023

2.20

169.24

2.6

3.0

—

Symptoms and signs involving the urinary system

1377

4601

2.32

169.18

3.1

2.8

—

Other symptoms and signs involving the nervous and musculoskeletal systems

814

2893

2.88

164.90

2.8

2.9

—

Other respiratory diseases principally affecting the interstitium

518

1414

3.85

164.05

4.3

2.7

—

Extreme obesity with alveolar hypoventilation

194

213

10.26

163.48

5.2

2.6

—

Paroxysmal tachycardia

343

537

5.47

162.63

3.2

2.2

—

Substance abuse, excluding more controls

1015

3404

2.59

162.20

2.9

2.8

—

Gout

693

1983

3.18

160.40

3.7

2.8

—

Care involving use of rehabilitation procedures

1013

3710

2.55

160.20

2.9

2.4

—

Hypertensive Heart Disease

495

984

4.06

160.10

3.6

2.6

—

Polyarthropathies

1216

3323

2.43

159.78

3.4

2.8

—

Depression medications

324

220

7.50

159.12

2.4

1.8

—

Pain, not elsewhere classified

500

1360

3.77

157.47

2.9

2.7

—

Diabetic nephropathy

569

1691

3.55

156.19

4.2

2.8

—

Volume depletion

310

589

5.59

156.05

4.4

2.5

—

Oedema, not elsewhere classified

613

1896

3.27

154.36

3.1

2.7

—

Syncope and collapse

797

2434

2.86

154.35

2.5

2.8

—

Asthma/COPD (KELA code 203)

1490

4756

2.18

154.29

3.3

2.7

—

Diseases of the respiratory system

879

1524

2.93

152.13

2.9

2.1

—

Ischaemic heart disease, wide definition

1279

3454

2.33

151.37

3.3

2.7

—

Biguanides

1512

4307

2.17

150.78

2.8

2.7

—

Complications of surgical and medical care, not elsewhere classified

1623

5407

2.08

150.28

3.4

2.6

—

Other and unspecified iron deficiency

700

2429

2.96

148.40

3.6

2.7

—

Pulmonary embolism

649

2172

3.08

147.21

3.3

2.7

—

Benzodiazepine use

1631

5536

2.05

145.82

2.9

2.7

—

Other disorders of kidney and ureter

380

906

4.43

145.47

5.3

2.8

—

Disorders of other endocrine glands

798

2958

2.71

143.86

4.3

2.7

—

Headache

926

2929

2.56

143.31

2.7

—

Pulmonary heart disease

649

2206

3.03

143.24

3.3

2.8

—

Autoimmune diseases excluding thyroid diseases

1653

4408

2.07

142.76

3.3

2.7

—

Symptoms and signs involving the nervous and musculoskeletal systems

1042

4472

2.37

142.62

2.8

2.9

—

Myocardial infarction

885

2386

2.67

142.45

3.6

2.6

—

Problems related to lifestyle

241

392

6.41

142.07

2.4

2.7

—

Personality disorders, excluding more controls

418

1080

3.96

141.61

2.6

—

Diseases of arteries, arterioles and capillaries

1230

4094

2.26

141.17

3.5

2.7

—

Hypokalaemia

312

649

5.04

141.12

3.4

2.4

—

Bacterial pneumoniae

677

2056

2.96

140.76

3.7

2.2

—

Gout, FINNGEN

693

2467

2.90

140.11

3.7

2.8

—

Abnormal findings on diagnostic imaging of lung

948

3763

2.47

139.95

3.5

2.8

—

Sub-endpoint used in defining T1D endpoints

624

2069

3.05

138.98

3.5

2.9

—

Later onset COPD

694

1936

2.96

137.94

3.6

2.5

—

Other disorders of urethra and urinary system

1162

3717

2.29

137.55

3.5

2.7

—

Glomerulonephritis

305

639

5.07

137.39

5.7

3.0

—

Haemorrhage from respiratory passages

641

1967

3.01

137.18

3.3

2.8

—

Retention of urine

755

2292

2.78

136.03

3.1

2.8

—

Neurological diseases

1238

2727

2.31

135.66

2.6

2.9

—

Autoimmune diseases excluding thyroid diseases, strict definition

1591

4287

2.06

135.12

3.3

2.7

—

GASTRO-related operations

1126

2382

2.40

134.12

3.1

2.3

—

Any gastric operation

1126

2382

2.40

134.12

3.1

2.3

—

Neurological diseases, wide definition

394

411

4.88

133.71

2.8

2.4

—

Other interstitial pulmonary diseases

433

1204

3.78

133.67

4.5

2.7

—

Poisoning by drugs, medicaments and biological substances

445

1252

3.65

133.59

2.6

2.7

—

Venous thromboembolism

1000

4194

2.35

132.65

3.1

2.8

—

Interstitial lung disease endpoints

433

1216

3.74

131.72

4.5

2.7

—

Interstitial lung disease

433

1216

3.74

131.72

4.5

2.7

—

Persons with potential health hazards related to communicable diseases

611

2077

2.97

131.69

3.5

2.8

—

Convulsions, not elsewhere classified

422

1140

3.74

131.41

3.8

2.8

—

ILD, hospital admissions

426

1188

3.77

130.97

4.5

2.7

—

Undetermined asthma, excluding more controls

215

338

6.54

130.53

3.6

2.1

—

Lung cancer and mesothelioma

353

708

4.40

130.51

2.8

2.3

—

Disorders of lens

1121

3080

2.31

130.21

3.6

2.7

—

Mental and behavioural disorders due to psychoactive substance use

1050

4336

2.28

129.69

2.9

2.8

—

Major coronary heart disease event excluding revascularizations

1019

2894

2.39

129.57

3.4

2.6

—

Codeine

1351

3450

2.15

128.71

2.8

2.5

—

Asthma, hospital admissions , main diagnosis only

1316

5646

2.08

128.66

2.9

—

Anaemia in chronic diseases classified elsewhere

141

11.70

128.06

5.6

2.9

—

Opioids

1411

3495

2.12

127.95

2.8

2.5

—

Pleural effusion

404

1104

3.83

127.67

3.6

2.4

—

DVT of lower extremities and pulmonary embolism

821

3322

2.52

127.38

3.2

2.8

—

Hydronephrosis

275

562

5.11

126.92

3.7

2.6

—

Poisoning by medicine

407

1122

3.73

126.03

2.6

2.8

—

Other antidepressants

1598

4118

2.01

125.63

2.8

2.7

—

Pure hypercholesterolaemia

1124

3316

2.24

123.95

2.8

2.6

—

Substance abuse

1015

4290

2.26

122.99

2.9

2.8

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

426

1224

3.54

122.61

2.4

2.8

—

Insulin, fast-acting (human)

309

714

4.48

122.35

3.8

2.5

—

Disorders of mineral metabolism

228

412

5.84

121.11

3.8

2.4

—

Fitting and adjustment of other devices

657

2191

2.77

121.04

2.4

2.5

—

Disorders of gallbladder, biliary tract and pancreas

1540

5005

1.96

119.39

3.0

2.7

—

Unknown and unspecified causes of morbidity

188

284

6.96

119.37

3.3

2.6

—

Non-invasive ventilation

299

594

4.57

119.01

5.6

2.2

—

Genitourinary diseases

853

1676

2.58

118.21

3.7

2.3

—

Other functional intestinal disorders

822

3185

2.44

118.14

3.1

3.0

—

General examination and investigation of persons without complaint and reported diagnosis

1112

2613

2.25

116.42

3.2

2.7

—

Asthma, including avohilmo

1797

5476

1.86

116.08

3.0

2.8

—

Peripheral artery disease

884

3023

2.38

115.88

3.6

2.7

—

Schizophrenia or delusion, excluding more controls

493

1597

3.12

115.54

3.0

2.7

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

429

549

3.96

115.38

2.5

2.6

—

Invasive ventilation

234

455

5.50

115.21

5.6

2.7

—

Implicit fungal Sepsis

192

309

6.60

115.06

5.0

2.0

—

Conduction disorders

517

1376

3.12

114.71

3.4

2.3

—

Gout, idiopatic and unspecified

585

2131

2.84

114.21

3.8

2.8

—

Angina pectoris

909

2599

2.37

114.00

2.9

2.6

—

Gout, unspecified

497

1659

3.11

113.97

3.7

2.8

—

Gout, strict definition

462

1492

3.23

112.35

3.9

2.8

—

Preparatory care for dialysis

179

278

7.12

112.14

6.1

2.9

—

Glucagon-like peptide-1 (GLP-1) analogues

483

1594

3.10

112.08

2.8

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

483

1594

3.10

112.08

2.8

—

Liquid cancers, helper endpoint

701

2418

2.59

111.98

3.0

2.9

—

Speech therapy

531

1854

2.95

111.79

2.8

—

Acute upper respiratory infections of multiple and unspecified sites

1154

4122

2.10

111.63

3.6

2.5

—

Undetermined asthma

215

397

5.57

110.65

3.6

2.1

—

ILD, hospital admissions 1, main diag only

376

1081

3.66

110.53

4.5

2.6

—

Autoimmune diseases

1639

4427

1.90

110.18

3.1

2.7

—

Diseases of oesophagus, stomach and duodenum

1598

5109

1.89

109.78

3.0

2.8

—

Bacterial pneumonia, not elsewhere classified

602

1961

2.75

109.75

3.8

2.2

—

Vocal cord dysfunction

194

283

6.29

109.17

2.9

2.3

—

Disorders of calcium metabolism

187

310

6.42

108.87

3.8

2.5

—

Hypertensive Renal Disease

141

173

8.87

108.30

4.2

2.6

—

Complications of procedures, not elsewhere classified

1249

5230

2.00

108.28

3.2

2.7

—

Other diseases of urinary system

1509

4470

1.92

106.62

3.3

2.8

—

Myocardial infarction, strict

775

2290

2.46

106.46

3.4

2.6

—

Infections of the skin and subcutaneous tissue

937

4301

2.19

106.44

3.8

2.8

—

Other reaction to severe stress, and adjustment disorders

531

1898

2.85

106.32

3.0

2.6

—

Substance use, excluding alcohol

369

1074

3.53

105.38

3.0

2.7

—

Adjustment and management of implanted device

399

1226

3.36

104.91

3.4

2.6

—

Intestinal infectious diseases

1713

5416

1.82

104.42

3.2

2.7

—

Diseases of the digestive system

849

3808

2.26

103.83

3.5

2.8

—

Abnormalities of heart beat

538

1923

2.79

103.33

2.6

2.7

—

Other retinal disorders

1106

4235

2.07

103.10

3.2

2.8

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

307

803

3.94

102.77

2.5

2.7

—

Explicit bacterial Sepsis

249

561

4.63

102.13

4.8

2.2

—

Contact with and exposure to communicable diseases

458

1538

3.02

101.92

3.0

2.9

—

1020

4342

2.10

101.75

3.0

2.8

—

Mood disorders, excluding more controls

1338

4126

1.96

101.71

2.7

—

987

4271

2.12

101.47

3.0

2.8

—

Other arrhythmias

818

2695

2.32

101.20

2.8

2.3

—

Other soft tissue disorders, not elsewhere classified

1430

4434

1.91

101.02

2.9

—

Cough

597

2192

2.62

100.54

2.8

—

Constipation

1379

5064

1.91

100.41

3.0

2.9

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

562

2138

2.69

100.15

3.5

2.7

—

Pain in limb

1257

4320

1.97

99.87

3.0

2.9

—

Senile cataract

989

2827

2.18

99.73

3.2

2.7

—

Mental and behavioural disorders due to alcohol

873

3876

2.20

99.67

2.9

2.8

—

Hernia of abdominal wall, postoperative

337

963

3.59

98.99

3.6

2.5

—

Myocardial infarction, without ST-elevation

802

3266

2.29

98.81

3.4

2.8

—

Diabetic retinopathy, excluding more controls

563

1123

2.90

98.15

3.5

2.5

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1444

5335

1.87

98.04

2.6

2.9

—

Injuries to the head

1635

5628

1.80

97.65

2.9

—

Unspecified haematuria

773

2813

2.32

97.21

3.0

2.9

—

Atherosclerosis, excluding cerebral and coronary sclerosis

807

2849

2.29

97.05

3.6

2.7

—

Disorders of adult personality and behaviour

433

1457

3.03

96.99

2.5

2.6

—

Certain infectious and parasitic diseases

998

2315

2.18

96.41

3.4

2.3

—

Used for control exclusion in common control thyroid runs

1520

4160

1.86

96.15

3.1

2.7

—

Diarrhoea and gastroenteritis of presumed infectious origin

1490

5398

1.84

96.06

3.3

2.7

—

Streptococcal septicaemia

223

485

4.82

95.82

5.0

2.4

—

Personality disorders

418

1389

3.07

95.77

2.6

—

Other diseases of blood and blood-forming organs, wide

436

1491

3.01

95.45

3.7

2.8

—

Unspecified mental disorder

626

2570

2.48

94.82

2.8

2.7

—

Kela-code for severe mental illness

578

2306

2.55

93.23

2.9

2.7

—

Anxiety disorders, excluding more controls

1112

3653

2.00

92.10

3.0

2.8

—

Other cataract

725

2381

2.35

91.62

3.8

2.7

—

Intracranial injury

946

4397

2.06

91.46

2.8

2.9

—

Alcohol use disorder, Swedish definition

918

4095

2.09

90.79

3.1

2.8

—

Codeine or tramadol medication

1623

5031

1.78

90.78

2.8

2.7

—

Bacterial pneumonia (organism specified)

773

3190

2.24

90.72

3.8

2.6

—

Type of accident

514

1970

2.67

90.32

3.5

2.7

—

Exposure to unspecified factor

1461

5896

1.80

89.84

3.1

2.8

—

Symptoms and signs involving the digestive system and abdomen

1435

3913

1.85

89.35

3.2

2.7

—

Chronic nephritic syndrome

147

235

6.82

89.35

4.4

2.5

—

Abdominal and pelvic pain

1432

3913

1.86

89.34

2.9

2.7

—

Low back pain

1117

4145

1.96

88.61

2.6

2.8

—

Complications of medical and surgical care

1117

5396

1.93

88.59

3.5

2.7

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

759

3471

2.21

88.53

3.0

2.8

—

Presence of cardiac and vascular implants and grafts

752

2498

2.28

88.45

3.1

2.8

—

Disorders of choroid and retina

1265

4857

1.87

87.80

3.2

2.8

—

Suicide or other Intentional self-harm

397

1353

3.00

87.13

2.5

2.7

—

Dental caries

471

1685

2.75

87.02

4.4

2.7

—

Use of hypnotics and sedatives

1540

5013

1.78

86.97

2.8

—

Depression

1319

4894

1.84

86.61

2.7

2.8

—

Caries of dentine

426

1477

2.87

85.76

3.9

2.7

—

Other disorders of skin and subcutaneous tissue

1072

4988

1.93

85.47

3.5

2.7

—

Any mental disorder

1541

4358

1.79

85.20

2.9

2.8

—

Cerebrovascular diseases

1169

4368

1.91

85.12

3.0

2.8

—

Alcohol use disorder, ICD-based

701

3172

2.25

85.09

2.9

2.8

—

GI-bleeding

627

2725

2.35

84.05

3.5

2.9

—

Mood [affective] disorders

1425

5213

1.79

83.91

2.7

2.8

—

Familial hypercholesterolemia

321

994

3.34

83.50

2.9

2.6

—

Mood disorders

1428

5227

1.78

83.45

2.7

2.8

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

426

1544

2.81

83.32

2.4

2.6

—

Osteopathies and chondropathies

860

3937

2.06

83.02

3.2

2.8

—

Schizophrenia, schizotypal and delusional disorders

495

1941

2.60

82.89

3.0

2.7

—

Schizophrenia or delusion

493

1934

2.60

82.48

3.0

2.7

—

Other diseases of the digestive system

623

2723

2.34

82.45

3.5

2.8

—

Acute peritonitis

198

447

4.71

81.74

5.9

2.9

—

Other symptoms and signs involving the urinary system

257

701

3.83

81.65

3.1

2.8

—

Adrenocortical insufficiency

123

179

7.44

81.55

3.4

2.6

—

Diagnoses used for exclusion with ILD

494

1964

2.58

80.75

3.2

2.8

—

Implicit fungal Sepsis

121

177

7.37

79.77

5.5

1.9

—

Non-allergic asthma (mode), excluding more controls

229

576

4.00

79.40

3.2

2.1

—

Fungal Sepsis

127

197

6.92

79.19

5.4

1.9

—

Viral and other specified intestinal infections

340

1090

3.11

79.15

5.2

2.5

—

Cholelithiasis, broad definition with cholecystitis

1246

4641

1.83

79.12

2.9

2.7

—

Hypothyroidism, drug reimbursement

137

136

7.21

78.74

3.0

2.0

—

Diseases of liver

577

2493

2.36

78.34

3.1

2.9

—

Morphin

120

9.27

77.35

5.3

2.4

—

Congenital malformations of the urinary system

161

321

5.31

76.99

5.8

4.0

—

Special screening examination for other diseases and disorders

242

658

3.80

76.82

3.1

2.7

—

Specific personality disorders

346

1172

3.01

76.76

2.6

—

Other disorders of adrenal gland

135

230

6.26

76.65

3.6

2.7

—

211

522

4.14

76.32

3.3

2.6

—

Fall on same level

1581

5116

1.70

75.56

3.1

2.8

—

Cardiomyopathy

301

952

3.24

75.39

3.6

2.4

—

Mouth breathing

632

2889

2.22

74.66

2.7

3.1

—

AV-block

326

935

3.13

74.60

3.5

2.3

—

Anxiety (asthma-related co-morbidities)

734

2700

2.12

74.35

2.8

—

Stroke, including SAH

1011

3900

1.91

74.28

3.0

2.9

—

Anxiety disorders

1175

4549

1.82

74.13

2.9

2.7

—

Nephrotic syndrome

120

190

6.91

73.75

7.9

3.1

—

Viral and other specified intestinal infections

405

1466

2.71

73.50

4.7

2.6

—

Neurotic, stress-related and somatoform disorders

1159

4508

1.82

73.04

2.9

2.7

—

ILD medications: azathioprine

244

690

3.63

72.96

6.3

2.4

—

Congenital malformations of the urinary system

162

340

5.02

72.91

5.8

3.9

—

Other anxiety disorders

581

2226

2.29

72.26

2.7

2.6

—

Pacemaker

639

2849

2.20

72.26

3.3

2.8

—

Cholelithiasis

1179

4565

1.80

71.73

2.9

2.7

—

Other diseases of intestines

1416

4717

1.72

71.34

2.9

2.8

—

Emphysema

188

453

4.35

71.12

4.0

2.5

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

433

1702

2.58

70.54

2.5

2.8

—

Continuous positive airway pressure

228

516

3.78

69.75

4.3

3.2

—

Ulcer of lower limb, not elsewhere classified

318

1092

3.01

69.52

3.8

2.8

—

All influenza (not pneumonia)

235

672

3.58

69.06

4.7

2.2

—

Pneumonia due to other infectious organisms, not elsewhere classified

104

152

7.34

68.59

4.3

2.6

—

Cutaneous abscess, furuncle and carbuncle

411

1619

2.59

68.38

3.7

2.8

—

Cystitis

1161

3882

1.79

68.11

3.1

2.7

—

Alcohol abuse, main dg, excluding more controls

262

812

3.31

67.93

3.0

2.8

—

Dorsalgia

1363

4274

1.72

67.91

2.5

2.8

—

Idiopathic pulmonary fibrosis

219

612

3.78

67.58

5.1

2.7

—

Stroke, excluding SAH

959

3777

1.88

67.57

3.0

2.9

—

Factors influencing health status and contact with health services

410

736

2.83

67.54

2.8

2.3

—

Cellulitis

379

1446

2.68

67.44

4.4

2.9

—

Azathioprine

244

727

3.44

67.35

6.3

2.6

—

Certain disorders involving the immune mechanism

335

1205

2.85

66.95

3.6

2.9

—

Diseases of peritoneum

230

667

3.59

66.69

5.5

2.9

—

Exclusions for E4_PCOS_BROAD

306

1051

2.99

66.47

3.7

3.5

—

Selective serotonin reuptake inhibitors

1355

4154

1.72

66.37

2.6

2.7

—

Cystic kidney disease

109

174

6.78

66.31

5.1

3.0

—

Cardiomyopathies, Primary/intrinsic

230

668

3.55

66.27

3.7

2.4

—

Epilepsy

468

1984

2.39

65.80

2.6

3.2

—

Sequelae of external causes of morbidity and mortality

439

1819

2.47

65.72

3.4

2.8

—

Enlarged lymph nodes

243

733

3.39

65.71

2.8

2.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

291

945

3.06

65.63

5.0

3.3

—

Autoimmune diseases related-to ILD

1144

5660

1.74

65.49

3.2

2.6

—

Disorders of parathyroid gland

370

1398

2.68

65.44

4.3

2.6

—

Psychiatric diseases

1327

3901

1.72

64.44

2.9

—

Other CVD

405

1635

2.55

64.39

2.9

—

Lower back pain or/and sciatica

1436

5725

1.65

63.97

2.7

2.8

—

Other bacterial intestinal infections

334

1239

2.76

62.97

3.8

2.7

—

Non-allergic asthma (mode)

229

675

3.41

62.94

3.2

2.1

—

Ischaemic Stroke, excluding all haemorrhages

907

3668

1.87

62.81

2.8

2.9

—

Cardiomyopathy (excluding other)

231

697

3.41

62.70

3.7

2.4

—

Other viral diseases

423

1753

2.45

62.62

5.3

2.7

—

Lung diseases due to external agents

312

1123

2.87

62.58

3.4

2.8

—

Hypotension

365

1426

2.64

62.26

3.0

2.8

—

Other and unspecified nonorganic psychotic disorders

287

987

2.97

62.13

2.9

2.7

—

Iron deficiency anaemia secondary to blood loss (chronic)

311

1124

2.84

61.74

3.2

2.7

—

Paralytic ileus and intestinal obstruction

450

1939

2.37

61.58

3.2

2.8

—

Other or unspecified ileus, impaction or obstruction

352

1356

2.66

61.53

3.1

2.8

—

Diabetic retinopathy, strict definition

434

1622

2.46

61.30

3.8

2.8

—

All anxiety disorders

751

3061

1.96

61.28

2.8

2.7

—

Dizziness and giddiness

1048

4765

1.76

61.10

2.6

2.9

—

Cystic kidney disease

109

189

6.19

60.97

5.1

3.1

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

137

7.15

60.66

4.1

2.2

—

Diabetic maculopathy

339

1218

2.74

60.58

3.6

2.8

—

Non-selective monoamine reuptake inhibitors

537

2407

2.18

60.53

2.9

2.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

295

1012

2.90

60.48

5.0

3.2

—

Other sleep disorders

200

564

3.65

60.27

3.2

3.1

—

Abnormal results of function studies

182

483

3.91

60.16

3.2

2.9

—

Other/unspecified dorsalgia

552

2586

2.15

60.04

2.8

—

Other/unspecified cytomegaloviral diseases

105

8.59

59.85

5.8

2.6

—

Cardiac arrest

112

162

6.09

59.78

3.7

2.1

—

Viral hepatitis, IBD co-morbidity

8.66

59.39

2.9

2.3

—

Obesity, other/unspecified

429

1842

2.36

59.02

2.9

2.6

—

Emotionally unstable personality disorder

187

511

3.75

58.92

2.6

2.4

—

Polycystic kidney disease

141

7.09

58.28

5.3

2.7

—

Tubulo-interstitial nephritis, not specified as acute or chronic

133

285

4.83

58.14

3.3

2.4

—

Enterocolitis due to Clostridium difficile

233

750

3.22

57.11

3.9

2.8

—

Attention to artificial openings

114

219

5.53

57.01

4.4

2.6

—

Other disorders of glucose regulation and pancreatic internal secretion

185

516

3.72

56.93

4.1

3.2

—

Bacterial intestinal infections, IBD co-morbidities

333

1299

2.63

56.84

3.8

2.8

—

Gastrointestinal diseases

702

1752

2.02

56.64

3.1

2.4

—

Mental and behavioural disorders due to opioids

135

6.92

56.46

3.0

2.0

—

Other and unspecified effects of external causes

392

1655

2.41

56.18

3.2

3.0

—

Unstable angina pectoris

564

2147

2.11

55.75

3.1

2.6

—

Intestinal stricture

512

2429

2.15

55.50

3.2

2.8

—

Diseases of the skin and subcutaneous tissue

1326

4067

1.65

55.43

3.1

2.6

—

Other general symptoms and signs

102

178

5.89

55.42

2.6

2.4

—

Drug-induced adrenocortical insufficiency

106

8.21

55.40

3.4

3.2

—

Elevated blood glucose level

185

527

3.65

55.23

3.2

2.9

—

Depression or dysthymia

892

2711

1.83

55.22

2.8

—

Hypercalcemia

123

260

5.04

55.20

3.6

2.9

—

Injuries to the thorax

699

3704

1.91

55.16

2.9

2.8

—

Spondylopathies

1089

3823

1.72

55.15

2.7

2.8

—

Dysphagia

391

1665

2.39

55.08

3.6

2.8

—

Sequelae with surgical and medical care as external cause

353

1439

2.51

54.96

3.4

2.9

—

Osteoporosis

430

1776

2.31

54.94

3.4

2.8

—

Other disorders involving the immune mechanism, not elsewhere classified

100

177

6.07

54.81

4.6

2.6

—

Acute upper respiratory infections

1380

5331

1.61

54.63

3.4

2.6

—

Agranulocytosis

211

657

3.32

54.61

3.9

2.8

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

858

4791

1.79

54.59

3.6

2.7

—

Dermatitis

845

4746

1.79

54.49

3.2

2.8

—

Hyperparathyroidism

317

1218

2.63

54.40

4.5

2.6

—

Other viral diseases

488

2267

2.16

54.39

4.8

2.6

—

Acute alcohol intoxication, ICD10

334

1332

2.56

54.39

2.8

2.9

—

Nerve, nerve root and plexus disorders

1422

5517

1.59

53.94

2.9

2.8

—

Sulfonylureas

579

2279

2.06

53.83

3.2

2.9

—

Delirium, not induced by alcohol and other psychoactive substances

268

964

2.87

53.75

3.0

2.9

—

Cytomegaloviral disease

132

7.03

53.26

5.6

2.6

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

599

3017

1.99

53.24

2.9

2.8

—

Cytomegalovirus infection, IBD co-morbidity

129

7.13

53.24

5.6

2.9

—

Statin medication

816

2490

1.86

53.10

3.2

2.5

—

Familial hypercholesterolemia, with ischemic heart disease

205

640

3.33

53.02

2.9

2.7

—

Other pleural conditions

218

706

3.20

52.96

3.8

2.4

—

Symptoms and signs concerning food and fluid intake

176

497

3.63

52.81

4.4

2.8

—

ILD-related respiratory insufficiency

110

221

5.38

52.63

7.4

2.6

—

Schizophrenia

250

878

2.91

52.28

3.2

2.8

—

Artificial opening status

126

284

4.65

52.05

4.1

2.6

—

Alcohol abuse, main dg

262

950

2.82

51.69

3.0

2.9

—

Other special examinations and investigations of persons without complaint or reported diagnosis

916

2615

1.79

51.43

3.2

2.7

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

134

319

4.34

51.37

2.4

2.3

—

Disorders of thyroid, IBD co-morbidities

166

298

3.96

51.30

3.0

2.3

—

Other symptoms and signs involving the circulatory and respiratory systems

125

283

4.57

51.09

3.2

2.6

—

Other bacterial intestinal infections

361

1536

2.39

51.01

3.7

2.7

—

Acute alcohol intoxication

413

1863

2.26

50.86

3.1

2.8

—

Failure and rejection of transplanted organs and tissues

10.49

50.79

11.6

3.0

—

Coagulation defects, purpura and other haemorrhagic conditions

324

1318

2.51

50.67

3.8

2.8

—

Spondylosis

768

3474

1.82

50.59

2.7

2.9

—

Other infectious diseases

194

605

3.32

50.22

3.7

2.8

—

Hypothyroidism, strict autoimmune

927

3539

1.74

50.08

2.9

2.6

—

Alcohol dependence

424

1950

2.21

49.80

2.9

2.8

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

137

340

4.18

49.77

2.6

—

Other diseases of liver

287

1113

2.64

49.61

3.1

2.8

—

Other neurological diseases

1026

4880

1.67

49.27

2.9

2.8

—

Gastro-oesophageal reflux disease

904

4589

1.72

48.99

2.9

2.8

—

Malignant neoplasm, wide definition for exclusion

1084

3849

1.66

48.92

2.9

2.8

—

Other condition

237

841

2.89

48.74

4.1

2.8

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1279

5196

1.59

48.74

3.2

2.7

—

Finngen Rheumatological endpoints

1209

4277

1.62

48.73

3.0

2.7

—

Traumatic subdural haemorrhage

239

815

2.88

48.58

2.8

2.9

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

170

5.81

48.21

4.9

2.6

—

Secondary right heart disease

112

245

4.84

48.20

4.6

3.3

—

Unspecified acute lower respiratory infection

249

913

2.79

48.11

4.4

2.7

—

Malignant neoplasm

1053

3763

1.67

48.08

2.8

—

Abnormal findings on examination of blood, without diagnosis

733

3768

1.81

48.02

3.5

2.9

—

Abnormal spermatozoa

265

1010

2.72

47.90

2.8

2.9

—

Falls/tendency to fall

1381

4434

1.57

47.63

3.0

2.8

—

Open wound of head

778

4291

1.77

47.51

3.0

2.9

—

Persons encountering health services for specific procedures, not carried out

134

339

4.06

47.28

2.6

2.3

—

Acidosis

116

7.05

47.19

5.0

2.6

—

Pain (limb, back, neck, head abdominally)

950

2784

1.72

46.93

2.7

3.0

—

Peripheral arterial reconstruction

338

1455

2.39

46.86

3.8

2.8

—

Gout due to impairment of renal function

9.66

46.72

4.5

2.3

—

Second line medication for Crohn's disease

734

4158

1.78

46.62

4.1

2.7

—

Other pulmonary heart/vessel disease

121

289

4.42

46.59

4.4

3.3

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

303

1249

2.48

46.14

2.6

2.8

—

Mental and behavioural disorders due to sedatives or hypnotics

132

338

4.04

45.97

2.9

2.5

—

Leisure time condition

294

1198

2.51

45.86

3.0

2.9

—

Thrombocytopenia, unspecified

161

474

3.54

45.85

4.3

2.8

—

Acute pancreatitis

316

1334

2.42

45.59

3.5

2.8

—

L04AX Other immunosuppressants

713

4038

1.78

45.35

4.2

2.7

—

Acute sinusitis

612

3054

1.87

45.20

3.0

2.5

—

Purpura and other haemorrhagic conditions

241

902

2.74

44.91

3.8

2.9

—

Charcot foot

8.64

44.58

4.4

2.6

—

Mycoses

390

1816

2.18

44.45

3.7

2.9

—

Other viral diseases, not elsewhere classified

277

1112

2.53

44.26

5.9

2.9

—

Recurrent or chronic depression

447

1501

2.11

44.18

2.5

2.7

—

Other and unspecified dermatitis

685

3867

1.79

44.16

3.2

2.8

—

Chronic apical periodontitis

1433

5402

1.52

44.15

2.7

2.8

—

Diseases of the myoneural junction and muscle

232

860

2.78

44.13

3.3

2.9

—

Gastroduodenal ulcer

437

2127

2.08

44.05

3.3

2.8

—

Bipolar affective disorders

236

880

2.72

44.00

2.5

2.7

—

Pneumocystosis

109

7.07

43.89

5.0

2.8

—

Motor neuron disease (with DMD)

7.92

43.82

4.2

3.5

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

163

497

3.38

43.72

3.2

2.7

—

Haemorrhage, not elsewhere classified

171

5.39

43.36

3.1

2.9

—

Mixed and other personality disorders

133

357

3.83

43.26

2.6

2.5

—

Motor neuron disease

8.06

43.00

4.3

3.3

—

Other specified and unspecified personality disorders

146

419

3.58

42.98

3.0

2.6

—

Combinations of oral blood glucose lowering drugs

401

1915

2.13

42.85

2.5

2.9

—

Other headache syndromes

449

2231

2.03

42.69

2.7

3.0

—

Hypoglycaemia, other or unspecified

143

410

3.62

42.35

4.0

3.4

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

778

4605

1.70

42.19

3.6

2.7

—

Other diseases of pericardium

202

4.91

42.16

4.3

2.5

—

Vitreous haemorrhage

198

693

2.95

42.04

4.0

2.9

—

Pneumonitis due to solids and liquids

188

644

3.02

41.60

3.5

2.8

—

Asthma mixed form (mode), excluding more controls

127

5.97

41.38

2.0

2.1

—

Abnormal findings on examination of urine, without diagnosis

109

265

4.32

41.00

4.0

2.8

—

IgA nephropathy (IgA glomerulonephritis)

134

6.02

40.79

5.1

2.3

—

Ascites

147

440

3.46

40.73

3.1

3.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

389

1875

2.11

40.70

3.2

2.9

—

Other symptoms and signs involving the digestive system and abdomen

231

890

2.64

40.47

3.6

2.7

—

Viral infections characterized by skin and mucous membrane lesions

556

3026

1.86

40.45

3.9

2.9

—

Other dorsopathies, not elsewhere classified

1254

4288

1.54

40.32

2.5

2.8

—

Diabetic retinopathy

694

2474

1.79

39.94

3.4

2.9

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

326

1455

2.24

39.91

4.9

2.6

—

Peripheral artery operations in Hilmo

243

970

2.57

39.77

3.9

2.6

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

244

976

2.56

39.73

2.6

3.1

—

Other diseases of intestine

241

962

2.56

39.42

3.4

2.8

—

Fibrosis and cirrhosis of liver

154

486

3.28

39.25

3.2

2.9

—

Noninfective enteritis and colitis

603

3392

1.79

39.24

3.5

2.8

—

Other viral diseases, not elsewhere classified

339

1561

2.19

39.13

5.1

2.7

—

Other and unspecified drugs and medicaments

156

499

3.22

38.78

3.1

2.8

—

Status post-ami

401

1489

2.09

38.66

3.0

2.6

—

Injuries to the hip and thigh

690

3659

1.73

38.64

2.9

2.8

—

Hernia of abdominal wall

630

3615

1.76

38.56

3.5

2.9

—

Ill-defined and unknown causes of mortality

194

707

2.84

38.38

4.1

2.8

—

Cirrhosis of liver, NAS

127

361

3.69

38.35

3.2

2.8

—

Other ill-defined and unspecified causes of mortality

180

632

2.96

38.21

4.1

2.9

—

Isolated proteinuria with specified morphological lesion

9.39

38.11

5.0

2.1

—

Amputation

207

782

2.73

38.05

4.1

2.7

—

Fentanyl

186

663

2.87

37.98

3.3

2.6

—

Neoplasms

888

2875

1.65

37.96

3.0

2.7

—

Emotional disorders starting during childhood or adolecense, excluding more controls

110

6.09

37.89

2.4

6.3

—

Candidiasis

365

1763

2.10

37.84

3.3

2.8

—

Other infectious diseases

159

523

3.15

37.79

3.9

2.9

—

Diverticular disease of intestine

924

3686

1.61

37.74

3.0

2.7

—

Other arthritis (FG)

409

2065

2.01

37.51

3.3

2.8

—

Arthropathies in other diseases classified elsewhere

194

4.76

37.51

4.0

3.1

—

Type 1 diabetes, strict (exclude DM2)

130

377

3.51

37.44

2.7

3.8

—

Type 1 diabetes, definitions combined

130

377

3.51

37.43

2.7

3.8

—

Other gastritis (incl. Duodenitis)

335

1580

2.16

37.09

3.3

2.8

—

Nonischemic cardiomyopathy

165

560

3.02

36.92

3.5

2.6

—

Cardiodefibrillation

560

3147

1.80

36.73

3.2

2.9

—

Solid cancers, helper endpoint

989

3717

1.58

36.72

2.8

—

Idiopathic gout

196

735

2.76

36.70

3.7

2.9

—

External causes of morbidity and mortality

799

2394

1.68

36.61

3.2

2.7

—

Systemic connective tissue disorders

471

2516

1.90

36.58

3.1

2.8

—

Type 1 diabetes, strict definition, subgroup 1

102

255

4.08

36.47

2.3

4.1

—

Fracture of rib(s), sternum and thoracic spine

451

2384

1.92

36.26

2.9

2.8

—

Chronic ulcer of skin, not elsewhere classified

144

459

3.25

36.14

3.8

2.7

—

Any event in cancer register

1079

4140

1.54

36.14

2.7

2.9

—

Acute pancreatitis (for exclusion)

316

1473

2.19

36.13

3.5

2.8

—

Diseases of the eye and adnexa

926

2891

1.61

36.12

3.1

2.6

—

Other disorders of bladder

214

843

2.61

36.12

3.2

2.8

—

Drug-induced neutropenia

137

424

3.35

36.08

2.9

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1143

4979

1.52

35.85

2.9

2.8

—

Protozoal diseases

167

5.02

35.56

4.6

2.7

—

Schizoaffective disorder

123

358

3.53

35.55

2.6

2.7

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

161

554

3.00

35.39

3.9

2.8

—

Chronic pancreatitis

206

806

2.62

35.24

3.2

2.9

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

6.90

35.07

2.3

—

Candidiasis

198

762

2.65

34.93

3.6

3.0

—

Malignant neoplasm of bladder, including Hilmo

237

990

2.44

34.79

3.3

2.7

—

Other systemic involvement of connective tissue (FG)

344

1659

2.07

34.56

3.0

2.7

—

Malignant neoplasm of bronchus and lung, including Hilmo

347

1410

2.10

34.55

2.8

—

Maltreatment syndromes

194

4.51

34.49

2.4

—

Type 1 diabetes, strict definition

105

279

3.83

34.48

2.5

3.9

—

Asthma mixed form (mode)

151

5.02

34.31

2.0

2.1

—

Osteomyelitis

137

438

3.25

34.27

4.2

2.8

—

Other external causes of accidental injury

1007

3251

1.56

34.20

2.9

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

251

1092

2.35

34.09

3.4

2.8

—

Acute and transient psychotic disorders

167

597

2.86

34.01

3.3

2.6

—

Other metabolic disorders

165

586

2.87

33.95

3.5

2.4

—

Calcific aortic valvular stenosis, operated

499

2697

1.82

33.82

3.1

2.9

—

Calcific aortic valvular stenosis

499

2697

1.82

33.82

3.1

2.9

—

Suppurative and necrotic conditions of lower respiratory tract

126

387

3.39

33.73

3.5

2.9

—

Calcific aortic valvular stenosis, diagnosis (helper)

498

2693

1.82

33.69

3.1

2.8

—

Operations 2 for CAVS

498

2693

1.82

33.69

3.1

2.8

—

Hypothyroidism, other/unspecified

1097

4819

1.51

33.52

2.9

2.8

—

Coronary artery bypass grafting

390

1477

2.00

33.40

3.0

2.6

—

Soft tissue disorders

1277

4489

1.47

33.31

2.9

—

Calcific aortic valvular stenosis, including rheumatic fever

499

2707

1.81

33.30

3.1

2.8

—

Other noninfective gastroenteritis and colitis

340

1680

2.05

33.18

4.0

2.9

—

Other complications of surgical and medical care, not elsewhere classified

153

531

2.95

32.98

3.1

2.7

—

Migraine

441

1908

1.89

32.97

2.6

3.1

—

Cholecystectomy

888

4957

1.56

32.96

2.9

2.8

—

Simple and mucopurulent chronic bronchitis

232

4.13

32.91

3.1

3.9

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

176

662

2.73

32.67

3.3

2.9

—

Rheumatoid arthritis

426

2040

1.89

32.57

2.9

2.7

—

Unspecified contracted kidney

13.81

32.40

6.9

2.8

—

Dissociative [conversion] disorders

137

5.13

32.13

2.4

2.1

—

Other and unspecified polyneuropathies, also in other diseases

306

1481

2.11

31.86

3.5

2.8

—

Dependence on enabling machines and devices, not elsewhere classified

8.08

31.80

13.2

2.1

—

Reimbursement for rheumatic diseases

688

4244

1.63

31.52

3.1

2.8

—

Chronic tubulo-interstitial nephritis

132

5.17

31.45

4.8

2.0

—

Other blood glucose lowering drugs, excl. Insulins

238

1050

2.31

31.24

3.2

2.9

—

Accidents

989

3251

1.53

31.06

2.9

—

Polyneuropathies and other disorders of the peripheral nervous system

337

1705

2.01

31.03

3.7

2.8

—

Bronchiectasis

132

438

3.10

30.92

3.7

2.7

—

Disorders of the thyroid gland

1162

5199

1.46

30.83

2.9

2.8

—

Osteoporosis with pathological fracture (FG)

127

419

3.12

30.09

3.2

2.5

—

Medical observation and evaluation for suspected diseases and conditions

808

2615

1.59

29.93

2.9

2.7

—

Injury, poisoning and certain other consequences of external causes

625

1855

1.70

29.84

3.3

2.8

—

Pyothorax

103

302

3.57

29.78

3.5

2.9

—

Phlebitis and thrombophlebitis (not including DVT)

304

1504

2.05

29.73

3.3

2.8

—

Decubitus ulcer and pressure area

129

434

3.08

29.64

4.2

2.8

—

Other and unspecified myopathies

161

611

2.71

29.47

3.0

2.8

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1001

4562

1.49

29.33

2.8

2.7

—

Myocarditis

5.67

29.30

4.8

1.8

—

Allergic asthma (mode), excluding more controls

172

656

2.59

29.29

2.1

2.0

—

Gastric ulcer

278

1341

2.11

29.19

3.2

2.8

—

Isolated proteinuria

158

4.67

29.10

4.4

2.3

—

Other diseases of anus and rectum

405

2216

1.85

29.07

3.1

2.8

—

Molar incisor enamel hypoplasia, with caries

9.06

29.04

15.9

5.3

—

Other specified/unspecified arthritis

344

1791

1.94

29.01

3.5

2.9

—

Other problems related to primary support group, including family circumstances

147

519

2.80

28.96

7.7

2.7

—

Functional dyspepsia

327

1680

1.97

28.69

2.6

2.7

—

Other degenerative diseases of the nervous system

322

1207

2.01

28.54

2.6

2.8

—

Non-small cell lung cancer, including Hilmo

255

1128

2.17

28.49

2.8

—

Unspecified fall

658

4081

1.60

28.27

2.9

—

Congenital malformations, deformations and chromosomal abnormalities

641

3816

1.61

28.11

3.8

2.7

—

Periapical abscess

535

3217

1.68

27.73

2.7

2.9

—

Ventral hernia

333

1744

1.94

27.70

3.5

2.8

—

Nonorganic sleeping disorders, excluding more controls

208

911

2.31

27.68

2.8

2.9

—

Duodenal ulcer

194

831

2.39

27.43

3.4

2.8

—

Neuromuscular dysfunction of bladder

146

547

2.73

27.37

3.3

2.8

—

Diseases of the musculoskeletal system and connective tissue

620

1882

1.66

27.34

2.7

2.9

—

Endocrine disorders, other/unspecified

5.75

27.31

3.2

2.5

—

Other follicular disorders

110

353

3.19

27.28

2.7

2.6

—

Fracture of femur

412

2093

1.81

27.25

2.9

2.8

—

Need for other prophylactic measures

104

324

3.31

27.19

3.6

3.5

—

Dorsopathies

1210

4328

1.43

26.96

2.6

2.9

—

Malignant neoplasm of bladder

140

520

2.77

26.76

3.6

2.7

—

Adverse effects, not elsewhere classified

242

1145

2.14

26.71

3.5

2.9

—

Non-Hodgkin lymphoma, all, including Hilmo

196

853

2.34

26.68

3.0

2.8

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

9.07

26.57

4.6

2.0

—

KRA_PSY_EATING, excluding more controls

215

3.80

26.57

2.8

3.1

—

Other disorders of white blood cells

101

314

3.33

26.53

3.8

3.2

—

Superficial injury of abdomen, lower back and pelvis

204

905

2.29

26.47

2.9

2.8

—

Fracture of lumbar spine and pelvis

321

1685

1.93

26.43

3.0

2.8

—

Status epilepticus

201

3.98

26.36

3.6

3.0

—

Migraine without aura

165

666

2.50

26.33

2.8

3.2

—

Other symptoms and signs involving cognitive functions and awareness

609

3481

1.61

26.24

2.4

2.9

—

Dermatitis and eczema

1333

5984

1.39

26.22

3.0

2.8

—

Hyperkinetic disorders, excluding more controls

105

318

3.20

26.20

2.5

3.6

—

Superficial injury of lower leg

304

1574

1.95

26.13

3.4

2.7

—

Disorders of magnesium metabolism

10.17

26.12

2.3

3.1

—

Sciatica+with lumbago

584

3342

1.62

26.11

2.8

—

Hypoplasia of dental enamel

7.29

26.04

17.2

5.5

—

Diseases of pulp and periapical tissues, including avohilmo

1264

4679

1.41

25.97

2.6

2.9

—

Fibromyalgia

110

363

3.09

25.95

2.2

2.3

—

Injuries to the ankle and foot

774

4562

1.52

25.89

2.8

2.9

—

Disorder of lipoprotein metabolism, unspecified

191

834

2.33

25.80

2.4

2.6

—

Lung transplant status

10.43

25.78

10.7

2.3

—

Lung transplantation

10.42

25.78

10.7

2.3

—

Fracture of foot, except ankle

285

1453

1.98

25.64

2.6

3.0

—

Any operation in hilmo

11.85

25.60

1.9

1.1

—

Malignant neoplasm of urinary organs

157

631

2.55

25.57

3.4

2.8

—

133

4.76

25.57

4.1

2.4

—

Other and unspecified tonsillitis

333

1488

1.90

25.57

3.0

2.4

—

Spinal stenosis

661

3210

1.58

25.56

2.7

2.9

—

Type1 diabetes, definitions combined, early onset

274

3.42

25.55

2.4

4.4

—

Misadventures to patients during surgical and medical care

199

888

2.28

25.52

3.3

2.8

—

Eosinophilic disease (BM)

8.68

25.48

2.4

1.8

—

Malignant neoplasm of kidney, except renal pelvis

145

564

2.64

25.29

3.3

2.8

—

Other obstructive and reflux uropathy

171

4.15

25.26

4.3

2.1

—

Covid-19 suspected case

235

1124

2.11

25.19

3.1

2.5

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

210

964

2.22

25.16

3.9

2.8

—

Panic disorder

155

624

2.52

24.96

3.3

2.4

—

Pneumonia due to Streptococcus pneumoniae

195

3.92

24.95

3.3

2.4

—

Focal epilepsy

291

1510

1.95

24.91

2.8

3.0

—

Hypopituitarism

114

394

2.97

24.91

3.9

2.9

—

Hypocalcemia

128

4.80

24.88

4.0

2.8

—

Sulfasalazine

304

1600

1.92

24.86

2.8

2.4

—

Other systemic involvement of connective tissue

346

1903

1.84

24.73

3.0

2.8

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

210

855

2.21

24.65

2.8

3.2

—

Unspecified chronic bronchitis

179

4.05

24.63

2.8

2.2

—

Other specified disorders of kidney and ureter

184

4.03

24.62

3.9

2.5

—

Arthropathies

1043

3684

1.44

24.52

2.7

2.8

—

Viral pneumonia (known virus, not influenza)

159

4.30

24.45

5.3

2.8

—

Orchitis and epididymitis

161

669

2.46

24.43

3.0

2.9

—

Valvular operations

184

809

2.31

24.43

3.5

2.6

—

Abnormal findings on diagnostic imaging of other body structures

182

798

2.32

24.36

3.1

2.7

—

Nonalcoholic fatty liver disease

137

529

2.64

24.22

2.4

2.8

—

Polycystic ovarian syndrome, consortium definition

660

2502

1.57

24.21

2.6

—

Malignant neoplasm of respiratory system and intrathoracic organs

313

1386

1.91

24.16

2.9

2.8

—

Irritable bowel syndrome

303

1609

1.90

24.15

2.2

2.6

—

Dilated cardiomyopathy

202

931

2.22

24.10

3.5

2.9

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

318

3.20

24.08

3.8

2.7

—

Amputation of toe

140

550

2.63

24.06

4.0

2.8

—

Generalized anxiety disorder

159

660

2.44

23.98

2.4

2.5

—

Childhood asthma (age<16), excluding more controls

107

277

3.07

23.86

2.8

1.8

—

Endocarditis

157

4.22

23.83

3.4

2.2

—

Exclusions for E4_PCOS_CONSORTIUM

726

2992

1.53

23.80

2.8

2.9

—

Dental pulpitis, including avohilmo

977

4434

1.44

23.76

2.6

2.8

—

Allergic asthma (mode)

172

727

2.33

23.56

2.1

2.0

—

Noninfectious colitis NAS

189

854

2.25

23.55

3.6

2.8

—

Congenital malformations, deformations and chromosomal abnormalities

686

4177

1.52

23.52

3.6

2.7

—

Injuries to the neck

277

1446

1.94

23.33

2.4

2.7

—

Infection due to other mycobacteria

6.03

23.20

3.5

2.3

—

Urticaria and erythema

401

2344

1.73

23.19

3.1

3.0

—

Transient ischemic attack

676

3607

1.53

23.13

2.8

2.9

—

Rheumatism, unspecified

164

703

2.37

23.12

2.7

—

Aortic aneurysm

353

1958

1.79

23.05

3.4

2.7

—

Non-small cell lung cancer

171

743

2.33

23.02

2.9

2.7

—

Other (seronegative) rheumatoid arthritis, wide

250

1269

2.00

22.93

3.1

2.7

—

Other embolism and thrombosis

182

820

2.26

22.88

3.4

2.7

—

Zoster [herpes zoster]

258

1326

1.98

22.85

3.6

2.8

—

Fluid overload

27.90

22.83

6.0

2.8

—

Unspecified nephritic syndrome

133

4.52

22.83

4.9

2.3

—

Drug-induced hypoglycaemia without coma

5.56

22.82

4.3

2.7

—

Other endocrine disorders

302

3.14

22.81

8.4

3.6

—

Diseases of the ear and mastoid process

1346

4985

1.36

22.74

2.9

2.8

—

Malignant neoplasm of bronchus and lung

283

1235

1.93

22.71

2.8

2.7

—

Other diseases of pancreas

131

512

2.62

22.69

3.3

2.8

—

Childhood asthma (age<16)

107

286

2.97

22.64

2.8

1.8

—

Heartburn

142

576

2.51

22.64

2.8

2.9

—

Sequelae of cerebrovascular disease

500

2675

1.63

22.62

3.0

2.8

—

Systemic atrophies primarily affecting the central nervous system

289

3.24

22.57

3.9

3.1

—

Drug-induced osteoporosis with pathological fracture

5.41

22.51

4.0

2.5

—

Cholecystitis

207

988

2.13

22.50

2.8

—

Seropositive rheumatoid arthritis

302

1640

1.85

22.24

3.0

2.7

—

Immunodeficiencies

246

3.40

22.14

4.0

3.1

—

Meniscus derangement

664

2946

1.53

22.09

2.6

2.7

—

Rheumatoid arthritis, including avohilmo

456

2798

1.65

22.01

2.8

—

Intentional self-harm by sharp object

5.36

21.88

2.3

2.2

—

Benign neoplasm of other and unspecified endocrine glands

180

827

2.22

21.61

3.3

2.8

—

Persistent mood disorders

219

1084

2.04

21.53

3.0

2.8

—

Psoriatic and enteropathic arthropathies

144

602

2.43

21.52

2.7

—

Right bundle-branch block

174

3.86

21.50

3.6

2.3

—

Pain associated with micturition

153

658

2.37

21.48

3.1

—

Diabetic neuropathy

240

1229

2.00

21.47

3.8

2.9

—

Presbycusis

245

1255

1.97

21.39

2.7

2.9

—

Acute pharyngitis

156

671

2.33

21.34

4.1

2.5

—

Cardiomyopathy, other and unspecified

105

378

2.84

21.33

4.2

2.3

—

Open wound of lower leg

203

982

2.10

21.31

3.5

2.7

—

Malnutrition

132

4.40

21.28

3.4

4.9

—

Focal epilepsy, strict definition

265

1408

1.91

21.24

2.9

3.0

—

Secondary uncertain malignant neoplasm

184

859

2.18

21.23

2.6

3.0

—

Organic, including symptomatic, mental disorders

703

3376

1.50

21.16

2.6

2.9

—

severe traumatic brain injury, does not include concussion

325

1845

1.79

21.05

2.8

—

Thiazolidinediones

161

716

2.29

20.97

3.0

—

Pulmonary oedema

121

4.55

20.94

3.7

2.1

—

Somatoform disorder

182

850

2.17

20.90

2.7

—

Other diseases of oesophagus

149

643

2.37

20.83

3.1

2.8

—

Personal history of certain other diseases

6.38

20.80

3.0

1.9

—

Emotional disorders starting during childhood or adolescence

195

3.59

20.68

2.5

5.1

—

Urolithiasis

438

2707

1.64

20.63

2.9

—

Other disorders of ear

1088

5210

1.37

20.54

2.8

2.9

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

130

530

2.49

20.51

3.0

2.3

—

Other/unspecified rheumatoid arthritis

176

819

2.19

20.51

3.2

2.8

—

Symptoms and signs involving the skin and subcutaneous tissue

808

5559

1.43

20.45

2.8

2.9

—

Phobic anxiety disorders

132

542

2.46

20.41

2.8

2.5

—

Spirochaetal infections, other/unspecified

2124

0.34

20.40

2.2

3.0

—

Hernia

1084

5319

1.37

20.40

3.3

2.8

—

Myocardial infarction, unclassifiable

361

1893

1.73

20.37

3.3

2.8

—

Lyme disease

2102

0.34

20.27

2.2

3.0

—

Fracture of lower leg, including ankle

629

4185

1.50

20.21

3.1

2.7

—

Hyperosmolality and hypernatraemia

5.54

20.17

4.2

2.3

—

Assault

149

653

2.31

20.01

2.6

2.8

—

Acute suppurative otitis media

259

1294

1.88

19.97

3.5

2.6

—

Disorders of skin appendages

505

3246

1.56

19.94

3.2

2.7

—

Pneumothorax

111

427

2.66

19.91

4.6

2.3

—

Other spirochaetal diseases

2128

0.35

19.90

2.1

3.0

—

Folate deficiency anaemia

6.51

19.90

3.1

2.2

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

7.63

19.81

3.1

2.9

—

Previous suicide attempt

7.84

19.75

2.3

2.8

—

Mixed hyperlipidaemia

219

3.39

19.70

3.9

2.5

—

Malignant neoplasm of digestive organs

469

2333

1.60

19.64

2.9

2.8

—

Injuries to the shoulder and upper arm

999

5883

1.38

19.60

3.0

2.8

—

Urticaria

309

1764

1.77

19.55

3.1

3.0

—

Respiratory conditions due to other external agents

115

4.49

19.51

2.9

2.6

—

Emotional disorders and disorders of social functioning with onset specific to childhood

196

3.48

19.50

2.6

5.3

—

Mental and behavioural disorders due to tobacco

121

490

2.52

19.49

3.5

2.8

—

Mental and behavioural disorders due to cannabinoids

4.81

19.49

2.3

2.5

—

Disorders of psychological development

140

557

2.36

19.47

4.0

3.7

—

Pain in joint

600

2530

1.52

19.42

3.0

2.9

—

Other hearing loss

397

2378

1.65

19.41

2.7

2.9

—

Alcohol-induced chronic pancreatitis

107

410

2.68

19.40

3.6

2.7

—

Clear cell adenocarcinoma of kidney

284

3.06

19.31

3.0

2.5

—

Diseases of male genital organs

689

2348

1.49

19.30

2.9

3.0

—

Other spirochaetal diseases

2155

0.36

19.29

2.3

3.0

—

Internal derangement of knee

420

2600

1.62

19.20

2.9

2.7

—

Arterial embolism and thrombosis

107

412

2.67

19.19

4.8

2.7

—

Smoking dependency

121

494

2.50

19.17

3.5

2.8

—

Personal history of risk-factors, not elsewhere classified

6.48

19.13

3.8

2.1

—

Parkinson's disease, excluding more controls

164

718

2.18

18.94

2.5

2.9

—

Non-small cell lung cancer, adenocarcinoma

105

404

2.67

18.90

3.1

2.8

—

Sarcoidosis

170

806

2.14

18.90

2.8

2.7

—

Redundant prepuce, phimosis and paraphimosis

268

1470

1.83

18.83

2.8

2.9

—

Superficial injury of hip and thigh

204

1036

2.00

18.78

2.9

2.8

—

Amputation of ankle bones

145

3.99

18.77

5.7

2.7

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

245

1324

1.87

18.70

2.8

3.0

—

Disorders of refraction and accommodation

286

1612

1.78

18.69

4.0

2.9

—

Tobacco use

279

3.02

18.57

2.8

2.6

—

Sensorineural hearing loss

924

4553

1.39

18.50

2.7

2.9

—

Viral infections characterized by skin and mucous membrane lesions

972

6117

1.36

18.40

3.2

2.8

—

Collagenous colitis

125

528

2.41

18.40

2.9

3.0

—

Umbilical hernia

334

1985

1.70

18.38

3.3

2.8

—

Superficial injury of head

283

1606

1.78

18.35

2.9

3.1

—

Hidradenitis suppurativa

142

3.91

18.32

2.6

2.2

—

Vitamin deficiency, wide

245

3.14

18.24

3.9

2.4

—

Vitamin deficiency

245

3.14

18.24

3.9

2.4

—

Sicca syndrome [Sjögren]

108

428

2.57

18.22

2.7

2.8

—

Degeneration of macula and posterior pole

623

3384

1.48

18.11

2.8

—

Coxarthrosis [arthrosis of hip](FG)

646

3112

1.47

18.07

2.8

—

Presence of other devices

297

1711

1.75

18.05

2.7

2.8

—

Injuries to the knee and lower leg

1368

5831

1.31

18.05

3.1

2.8

—

Benign intracranial hypertension

8.02

18.02

2.6

2.5

—

Oesophagitis

328

2.82

18.01

3.6

2.8

—

Polyuria

287

1647

1.76

17.98

2.8

—

Intestinal malabsorption

237

3.17

17.95

4.4

2.8

—

Other and unspecified local infections of skin and subcutaneous tissue

130

565

2.34

17.93

3.9

2.8

—

Myocardial infarction, with ST-elevation

269

1518

1.80

17.92

3.6

2.8

—

DVT of lower extremities

245

1343

1.85

17.91

3.1

2.7

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

495

3221

1.53

17.91

3.8

2.8

—

Other local infections of skin and subcutaneous tissue

136

604

2.29

17.83

3.8

2.8

—

Infective dermatitis

155

726

2.17

17.83

2.9

3.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

118

493

2.44

17.82

2.8

3.2

—

Open wound of ankle and foot

140

630

2.26

17.78

2.6

3.2

—

Deforming dorsopathies

307

1799

1.72

17.78

2.8

3.0

—

Migraine with aura

189

953

2.00

17.67

2.9

2.8

—

Problems related to social environment

142

3.86

17.57

2.9

2.4

—

Hypoparathyroidism

190

3.43

17.53

3.4

2.6

—

313

1740

1.71

17.49

2.8

2.9

—

Conductive and sensorineural hearing loss

951

4726

1.36

17.40

2.8

2.9

—

Disorders of eyelid, lacrimal system and orbit

983

5541

1.35

17.39

2.5

2.9

—

Intentional self-harm by unspecified means

6.48

17.38

2.4

2.7

—

Necrosis of pulp, including avohilmo

592

4048

1.47

17.31

2.7

2.8

—

Benign neoplasms

1135

4712

1.33

17.23

3.1

2.7

—

Primary adrenocortical insufficiency

6.26

17.22

4.0

2.6

—

Secondary polycythaemia

140

3.88

17.22

2.8

2.5

—

Other or ill-defined heart diseases

238

3.09

17.12

3.1

2.1

—

Other disorders of bone

213

1133

1.90

17.10

2.9

2.8

—

Fracture of shoulder and upper arm

426

2733

1.57

17.10

3.0

2.9

—

Pericarditis

154

3.67

17.09

4.0

2.2

—

Persons encountering health services for examination and investigation

743

2615

1.43

17.04

2.9

2.7

—

Papulosquamous disorders

439

2843

1.56

17.00

3.3

2.8

—

Vasculitis limited to skin, not elsewhere classified

146

3.78

16.96

4.7

2.7

—

Suppurative and unspecified otitis media

352

1909

1.64

16.95

3.7

2.6

—

Arthrosis

800

3139

1.41

16.87

2.6

2.7

—

Myalgia

245

1367

1.81

16.86

2.4

2.7

—

Speech disturbances, not elsewhere classified

140

646

2.21

16.81

3.2

2.8

—

421

2350

1.58

16.81

2.7

2.9

—

Multiple myeloma, including Hilmo

296

2.86

16.79

3.4

2.7

—

Use of disulfiram, acamprosate or naltrexone

114

483

2.40

16.70

2.5

3.0

—

Other and unspecified vasculitis limited to skin

134

3.89

16.66

4.8

2.7

—

Calculus of kidney and ureter

388

2457

1.60

16.65

2.9

3.0

—

Zoster [herpes zoster]

571

3858

1.47

16.64

3.2

2.8

—

Non-Hodgkin lymphoma, all

292

2.86

16.63

3.1

2.9

—

Other specified/unspecified systemic involvement of connective tissue

264

2.94

16.60

4.0

2.6

—

Use of pramipexole

274

1590

1.74

16.56

3.0

2.7

—

Alcoholic liver disease

146

689

2.16

16.55

3.8

2.8

—

Other joint disorders

945

3670

1.36

16.53

2.5

2.7

—

Other orthopaedic follow-up care

238

3.04

16.51

2.1

2.4

—

Other diseases of blood and blood-forming organs

104

427

2.49

16.39

3.2

2.8

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

6.09

16.36

3.9

2.7

—

Asthma and opportunity respiratory infection

262

2.95

16.30

2.6

2.7

—

Other eating disorders

183

3.34

16.28

3.0

2.6

—

Fitting and adjustment of external prosthetic device

31.82

16.28

7.1

3.1

—

Other specific joint derangements/joint disorders

754

3490

1.40

16.24

2.9

2.7

—

Adhesive capsulitis of shoulder

199

1055

1.91

16.21

2.9

2.8

—

Viral warts

120

527

2.31

16.19

4.8

3.1

—

Traumatic subarachnoid haemorrhage

160

3.53

16.15

2.5

3.4

—

Speech and linguistic disorders, excluding more controls

302

2.71

16.14

4.3

—

Post-traumatic stress disorder

268

2.87

16.08

2.1

2.4

—

Amenorrhoea

226

3.05

16.00

2.3

2.5

—

Vascular disorders of the intestines

117

512

2.34

16.00

3.0

2.8

—

Rash and other nonspecific skin eruption

129

589

2.23

15.88

3.6

3.5

—

Gonarthrosis [arthrosis of knee](FG)

835

3540

1.38

15.88

2.6

2.7

—

Coxarthrosis

595

2712

1.46

15.86

2.9

2.8

—

Psoriasis

315

1919

1.66

15.84

3.4

2.8

—

Drug-induced cataract

130

3.85

15.77

11.0

2.6

—

Eating disorders

107

451

2.40

15.76

3.1

2.8

—

Impotence

358

2.61

15.75

3.2

2.7

—

Carrier of infectious disease

112

4.07

15.71

3.9

2.4

—

Seronegative rheumatoid arthritis

142

676

2.13

15.70

3.1

2.7

—

Benign neoplasm: Parathyroid gland

5.71

15.67

3.3

2.7

—

Postprocedural disorders of digestive system, not elsewhere classified

189

3.28

15.61

4.9

2.5

—

Manic episode

136

3.71

15.46

2.8

2.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

549

2547

1.47

15.45

3.0

2.8

—

Other diseases of arteries and capillaries

124

564

2.24

15.44

3.5

2.7

—

Mycoses

939

6151

1.33

15.42

3.0

2.8

—

Spondyloarthritis

207

1131

1.85

15.34

2.8

2.7

—

Other and unspecified disorders of white blood cells

244

2.96

15.31

4.5

3.1

—

Disorders of lacrimal system

462

3088

1.50

15.29

2.7

2.8

—

Mental retardation, excluding more controls

180

3.27

15.29

3.2

5.2

—

Other disorders of lacrimal gland

380

2443

1.57

15.28

2.8

—

Pleural plaque

153

759

2.06

15.27

3.4

2.5

—

Other intervertebral disc disorders

893

3994

1.35

15.20

2.6

2.8

—

Irregular menses

373

1872

1.58

15.13

2.4

2.5

—

Dislocation, sprain and strain of joints and ligaments at neck level

160

807

2.01

15.11

2.2

2.7

—

Somnolence, stupor and coma

251

2.90

15.11

3.4

2.7

—

Inflammatory bowel disease

338

2120

1.61

15.11

3.4

2.7

—

Toxic effect of other and unspecified substances

6.01

15.08

2.7

2.6

—

Blood alcohol or alcohol intoxication level

111

4.01

15.07

3.0

2.3

—

Crohn disease

144

700

2.08

15.07

2.5

2.7

—

Left bundle-branch block

359

2.55

15.06

3.0

2.4

—

Abdominal aortic aneurysm (AAA)

173

892

1.96

15.05

3.7

2.7

—

Hyperplasia of prostate

493

1872

1.51

15.04

3.0

2.9

—

Cerebral palsy and other paralytic syndromes

145

709

2.08

14.98

4.0

2.9

—

Autism spe, excluding more controls

5.87

14.98

1.3

6.5

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

105

453

2.36

14.84

3.3

2.8

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

133

633

2.14

14.80

3.3

2.8

—

Injuries to the elbow and forearm

751

4846

1.37

14.70

3.0

2.8

—

Pneumonia derived septicemia

207

3.09

14.65

7.7

2.9

—

Symptoms and signs involving speech and voice

374

2421

1.56

14.62

2.8

—

Acute bronchiolitis

283

2.66

14.58

5.8

3.8

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

293

1792

1.65

14.57

3.1

2.8

—

Scoliosis

419

2.40

14.57

2.9

3.6

—

Seropositive rheumatoid arthritis, wide

302

1862

1.64

14.54

3.0

2.8

—

Transport accidents

470

2736

1.49

14.50

2.7

2.8

—

Inflammatory diseases of female pelvic organs

514

2592

1.46

14.42

2.7

2.6

—

Weight loss

139

681

2.08

14.34

4.0

3.1

—

Ulcerative colitis

263

1571

1.69

14.32

3.8

2.8

—

Other/unspecified seropositive rheumatoid arthritis

298

1839

1.64

14.31

3.1

2.8

—

Obsessive-compulsive disorder

225

2.93

14.29

2.0

2.2

—

Disorders of sclera, cornea, iris and ciliary body

592

4214

1.41

14.26

2.9

2.8

—

Nonsuppurative otitis media

229

1134

1.76

14.21

3.6

2.6

—

Multiple myeloma and malignant plasma cell neoplasms

341

2.57

14.21

3.4

3.0

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

273

1652

1.67

14.20

3.0

2.7

—

Arterial embolism and thrombosis of lower extremity artery

227

2.95

14.19

4.2

3.0

—

Open wound of forearm

124

584

2.16

14.17

3.4

2.6

—

Chronic viral hepatitis

232

2.90

14.16

3.0

2.2

—

Other diseases of biliary tract

116

533

2.21

14.13

3.8

2.8

—

Superficial injury of thorax

181

975

1.88

14.12

2.8

—

Psoriatic arthropathies

117

539

2.20

14.12

2.8

—

Eating disorder

322

2.57

14.10

2.8

3.0

—

Colectomy operation

218

1244

1.78

14.09

3.1

2.8

—

Bronchitis, not specified as acute or chronic

100

433

2.34

14.00

3.3

2.5

—

Other and unspecified injuries of lower leg

378

2.45

13.99

2.2

2.7

—

Other and unspecified follicular disorders

218

2.97

13.97

2.6

2.3

—

Neuralgia and neuritis, unspecified

245

2.83

13.96

2.5

3.0

—

Toxic effects of substances chiefly nonmedicinal as to source

135

661

2.07

13.92

2.6

2.9

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

5.02

13.92

3.8

2.4

—

Diseases of middle ear and mastoid

569

3288

1.42

13.89

3.4

2.6

—

Postmenopausal osteoporosis with pathological fracture

356

2.50

13.88

2.9

2.5

—

Varicose veins

702

3879

1.37

13.78

3.0

2.8

—

Nonorganic sleeping disorders

208

1178

1.78

13.74

2.8

—

Amiodarone users

154

796

1.97

13.73

3.0

2.9

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

105

470

2.29

13.73

3.1

2.9

—

Cholangitis (primary sclerosing, PSC)

376

2.44

13.72

4.6

2.9

—

Crohn's disease NAS

328

2.55

13.69

2.6

2.8

—

Symptoms and signs involving emotional state

138

3.50

13.67

2.4

2.9

—

Molar incisor enamel hypoplasia

156

3.29

13.65

14.3

4.5

—

Pediculosis, acariasis and other infestations

171

914

1.89

13.65

2.5

2.8

—

Other renal tubulo-interstitial diseases

4.14

13.64

3.8

1.8

—

Ulcerative ileocolitis

194

3.06

13.64

3.2

2.5

—

Other factor of the environment

5.44

13.59

2.8

2.1

—

Respiratory disorders in diseases classified elsewhere

4.49

13.59

5.7

2.4

—

Shock, not elsewhere classified

6.39

13.56

2.7

2.5

—

Open wound of abdomen, lower back and pelvis

154

3.34

13.51

3.7

2.5

—

Excessive vomiting in pregnancy

283

2.65

13.50

1.9

2.4

—

Other shoulder lesions

105

472

2.25

13.47

2.6

2.7

—

Parkinson's disease, strict definition, excluding more controls

144

694

2.00

13.43

2.4

2.9

—

Need for immunization against other single viral diseases

4.20

13.43

6.6

4.6

—

Asthma and allergy, excluding more controls

320

2.51

13.37

2.2

2.0

—

Congenital malformations of cardiac septa

374

2.40

13.30

4.3

4.6

—

Pneumonia due to Haemophilus influenzae

16.29

13.27

4.1

2.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

570

3964

1.40

13.27

2.6

2.8

—

Mental disorders, not otherwise specified

357

2.44

13.25

2.5

2.7

—

Cerebral cysts

328

2.52

13.22

3.0

—

Hypoplasia of dental enamel , including avohilmo

146

3.34

13.21

14.7

4.6

—

Polyarthritis, unspecified

182

3.10

13.20

3.0

3.2

—

Methotrexate

140

708

2.00

13.19

2.7

2.5

—

Injuries to the wrist and hand

1095

5941

1.28

13.10

2.7

2.9

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

347

2266

1.54

13.09

3.1

2.9

—

Secondary parkinsonism, excluding more controls

104

3.86

13.08

4.3

3.2

—

Abnormal involuntary movements

157

829

1.92

13.08

2.7

2.9

—

Congenital malformations of heart and great arteries

151

762

1.95

13.04

4.3

3.7

—

Other diseases of spinal cord

184

3.09

13.01

4.1

3.0

—

In situ neoplasms

439

3016

1.47

12.95

3.2

2.7

—

Non-follicular lymphoma

142

730

1.98

12.89

3.1

2.8

—

Protein-energy malnutrition of moderate and mild degree

5.10

12.85

3.9

6.7

—

Pyogenic arthritis

400

2.34

12.84

3.4

3.0

—

Polyarthrosis

232

1280

1.70

12.82

3.1

2.8

—

Atypical mycobacterium lung infection

4.74

12.80

3.2

2.3

—

Acne

399

2.33

12.78

3.2

2.2

—

Gonarthrosis

711

2984

1.36

12.77

2.5

2.7

—

Alzheimer disease, excluding more controls

201

744

1.80

12.73

2.4

2.9

—

Other and unspecified mood [affective] disorders

257

2.68

12.72

2.3

—

Discitis, unspecified

4.05

12.71

3.5

3.0

—

Use of biperiden

287

2.60

12.70

2.5

2.6

—

Pruritus

126

623

2.05

12.70

3.5

2.9

—

Agoraphobia

4.05

12.68

2.2

2.0

—

Pneumococcal septicemia

214

2.89

12.67

7.9

3.0

—

Gingival hyperplasia

214

2.89

12.66

12.5

3.2

—

Symptoms and signs involving appearance and behaviour

5.95

12.60

2.3

2.1

—

Late syphilis

4.53

12.59

4.7

2.3

—

Polyarteritis nodosa and related conditions

4.51

12.57

3.1

3.0

—

Hypothermia

117

3.66

12.57

2.9

2.5

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

544

3073

1.41

12.55

2.9

2.7

—

Psychotic depression

277

2.60

12.50

1.9

2.7

—

Colorectal cancer

280

1722

1.61

12.49

2.8

—

Lesion of ulnar nerve

158

849

1.88

12.49

3.0

2.9

—

Panhypopituitarism

3.90

12.43

3.0

2.8

—

Open wound of wrist and hand

473

3247

1.43

12.33

2.5

2.8

—

Mixed connective tissue disease

303

2.52

12.32

4.1

2.7

—

Immunodeficiency with predominantly antibody defects

128

3.47

12.31

4.4

3.1

—

Chondrocostal junction syndrome [Tietze]

179

3.03

12.30

2.3

2.5

—

Abnormal weight loss

125

625

2.03

12.28

3.4

3.2

—

Nontraumatic intracranial haemmorrhage

258

1599

1.63

12.27

3.3

2.8

—

Hepatic failure, not elsewhere classified

229

2.78

12.26

2.9

2.6

—

Other viral hepatitis

304

2.51

12.22

2.9

2.4

—

Ulcerative colitis, NAS

150

798

1.90

12.22

4.3

2.8

—

Adult respiratory distress syndrome

4.13

12.21

4.4

2.0

—

Total colectomy operation

224

2.79

12.17

4.1

2.4

—

Total colectomy

224

2.79

12.17

4.1

2.4

—

105

3.72

12.13

2.3

—

Otitis media, unspecified

114

506

2.10

12.11

5.0

2.6

—

Amyloidosis

120

3.54

12.07

4.3

2.6

—

Disorders of oesophagus in diseases classified elsewhere

130

3.44

12.07

3.7

2.5

—

Diseases of spleen

3.96

12.05

3.7

2.5

—

Carpal tunnel syndrome

617

4004

1.36

11.99

2.5

2.7

—

Benign neoplasm: Adrenal gland

105

497

2.15

11.97

3.2

2.7

—

Keratitis

372

2515

1.49

11.94

3.1

2.8

—

Primary hyperparathyroidism

128

652

1.99

11.92

3.2

2.8

—

Disorders of synovium and tendon

535

3375

1.39

11.90

2.8

—

Biological medication for rheuma

163

898

1.83

11.89

2.7

—

Intestinal adhesions without obstruction

114

558

2.08

11.88

2.9

3.1

—

Other skin changes

224

1353

1.67

11.85

2.9

—

Vitamin B12 deficiency anaemia

142

751

1.92

11.84

2.8

—

SLE (Finngen)

141

3.26

11.84

2.4

2.5

—

Shoulder lesions

840

3897

1.31

11.77

2.7

2.8

—

L01XE Protein kinase inhibitors

366

2.35

11.77

3.2

2.9

—

Congenital malformations of the circulatory system

160

853

1.84

11.74

4.3

3.6

—

Caries of enamel

527

5230

0.72

11.72

3.5

2.8

—

Injuries to unspecified part of trunk, limb or body region

127

649

1.98

11.72

3.2

2.9

—

Appendectomy

632

4490

1.35

11.69

2.7

—

Other abnormalities of plasma proteins

3.81

11.68

3.0

2.4

—

Disturbance of activity and attention

101

464

2.15

11.66

2.5

3.7

—

Persistent delusional disorders

437

2.21

11.62

3.3

2.8

—

Asthma and allergy

343

2.35

11.56

2.2

2.0

—

Excessive earwax

629

4571

1.35

11.55

2.9

—

Chronic gastritis

318

2098

1.53

11.53

2.9

2.7

—

Other abnormal findings in urine

100

3.77

11.51

3.1

2.4

—

Vascular diseases of the intestine

249

2.64

11.44

3.2

2.8

—

Chronic periodontitis, complicated

595

4366

1.36

11.38

3.0

2.8

—

Cyst of kidney

104

501

2.12

11.37

3.4

2.7

—

Herpesviral [herpes simplex] infections

127

656

1.96

11.36

3.4

2.7

—

Superficial injury of wrist and hand

195

1148

1.71

11.33

2.9

—

Dermatophytosis

162

908

1.81

11.25

3.8

2.9

—

Acute laryngitis and tracheitis

106

506

2.08

11.21

5.1

2.4

—

Lichen simplex chronicus and prurigo

367

2.30

11.21

3.9

2.7

—

Wide developmental disorders, excluding more controls

3.78

11.20

3.1

7.6

—

Calculus of lower urinary tract

434

2.20

11.09

2.6

2.8

—

Anorexia (incl.atypical)

252

2.57

11.09

3.4

2.3

—

Trigger finger

148

810

1.85

11.08

2.8

—

Corticotropin deficiency

5.71

11.04

3.4

2.6

—

Extrapyramidal and movement disorders

437

3095

1.42

11.02

2.7

2.9

—

Paralytic ileus

254

2.58

11.01

3.5

2.9

—

Eosinophilia

3.87

11.00

2.4

3.0

—

Other symptoms and signs involving general sensations and perceptions

225

2.68

10.98

3.1

2.8

—

Acne vulgaris

289

2.45

10.97

3.0

2.2

—

Benign paroxysmal vertigo

321

2147

1.51

10.94

2.7

2.8

—

Astigmatism

333

2.35

10.90

5.9

3.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

494

2431

1.40

10.90

2.8

—

Lifestyle-related condition

4.62

10.88

2.7

2.0

—

Excessive, frequent and irregular menstruation

329

1186

1.53

10.88

2.9

2.7

—

Radiculopathy

188

1110

1.71

10.87

2.9

2.8

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

325

2170

1.50

10.85

2.7

2.8

—

Malignant neoplasm of skin

529

2634

1.38

10.84

2.7

2.8

—

Alcohol withdrawal state with delirium

465

2.13

10.76

2.6

2.9

—

Focal brain injury

286

2.44

10.75

2.8

3.3

—

Other disorders of nervous system

426

2.18

10.72

2.6

2.9

—

Dermatographic urticaria

293

2.42

10.69

2.9

2.7

—

Late syphilis

3.78

10.66

4.5

2.2

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

136

3.21

10.59

3.6

2.5

—

Chronic laryngitis and laryngotracheitis

161

918

1.77

10.56

2.8

2.7

—

Heart failure and hypertrophic cardiomyopathy

116

3.42

10.56

5.2

2.5

—

Other ulcerative colitis

295

2.41

10.56

6.6

2.6

—

Other abnormal uterine and vaginal bleeding

212

919

1.66

10.53

2.4

2.7

—

Hepatomegaly and splenomegaly, not elsewhere classified

5.66

10.51

2.8

2.5

—

Conjunctivitis (acute, non atopic)

278

1812

1.54

10.51

3.0

3.2

—

Juvenile arthritis (FINNGEN)

179

2.84

10.46

4.0

3.0

—

Lumbar disc prolapse

636

3677

1.33

10.43

2.6

2.8

—

Complications following infusion, transfusion and therapeutic injection

4.08

10.43

3.2

2.7

—

Migraine without aura and triptan purchases

125

661

1.90

10.42

2.6

2.5

—

327

2.32

10.39

2.9

3.0

—

Acute gastritis

451

2.12

10.38

4.1

2.8

—

Fracture of skull and facial bones

216

1339

1.63

10.34

2.9

3.0

—

Dermatitis due to substances taken internally

286

2.42

10.31

3.1

2.6

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

115

595

1.96

10.30

3.9

3.5

—

Mixed disorders of conduct and emotions, excluding more controls

4.78

10.27

2.5

6.8

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

111

446

2.01

10.25

2.4

2.9

—

Other coagulation defects

388

2.20

10.22

3.8

2.7

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

5.31

10.21

5.3

2.2

—

Visual disturbances and blindness

552

4112

1.35

10.19

2.8

2.9

—

Scabies

136

745

1.84

10.19

2.4

2.7

—

Missing teeth due to accident, extraction or parodontitis

657

4725

1.32

10.18

3.1

2.8

—

Soft tissue disorders related to use, overuse and pressure

282

1867

1.52

10.12

3.0

2.8

—

Arthropathic psoriasis

122

649

1.90

10.06

3.0

2.7

—

Disorders of plasma-protein metabolism, not elsewhere classified

8.68

10.05

2.7

1.9

—

Disorders of vestibular function (Vertigo)

504

3653

1.36

10.01

2.4

2.8

—

Scabies

254

2.49

9.98

3.2

2.2

—

Allergic urticaria

399

2.16

9.93

3.4

2.8

—

Recurrent and persistent haematuria

5.15

9.93

2.6

1.9

—

Other female pelvic inflammatory diseases

138

766

1.82

9.91

2.4

2.7

—

Viral hepatitis

361

2.22

9.88

3.0

2.5

—

Acute posthaemorrhagic anaemia

197

2.70

9.85

4.6

2.8

—

Bacterial, viral and other infectious agents

494

2.03

9.85

3.6

3.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

153

805

1.76

9.75

2.0

2.5

—

Abscess of anal and rectal regions

462

2.06

9.75

3.4

2.8

—

Cluster headache, wide

137

3.04

9.73

3.1

2.7

—

Disorders of muscles

109

565

1.95

9.72

2.5

2.7

—

Diffuse large B-cell lymphoma, including Hilmo

276

2.41

9.72

3.0

2.7

—

Diffuse large B-cell lymphoma

276

2.41

9.72

3.0

2.7

—

Diffuse large B-cell lymphoma, helper endpoint

276

2.41

9.72

3.0

2.7

—

5-aminosalicylic acid

184

1114

1.66

9.69

3.9

2.4

—

Other disorders starting during childhood or adolecense, excluding more controls

146

2.92

9.67

3.5

5.8

—

Crohn's disease of large intestine

246

2.48

9.64

2.9

2.6

—

Vitamin D deficiency

3.73

9.63

3.7

2.6

—

Need for immunization against other single infectious diseases

25.29

9.61

8.2

2.6

—

Impetigo

205

2.63

9.61

4.2

3.0

—

Pediculosis, acariasis and other infestations

334

2.25

9.57

3.1

2.5

—

Glaucoma

650

4295

1.31

9.57

2.7

2.9

—

Other necrotizing vasculopathies

473

2.04

9.56

3.6

2.8

—

Other and unspecified urticaria

186

1134

1.65

9.56

2.9

3.0

—

Hyperkinetic disorders

105

528

1.96

9.56

2.5

3.6

—

Mental retardation

240

2.50

9.53

3.2

5.2

—

Nosocomial condition (hospital)

5.27

9.52

2.7

2.3

—

Evidence of alcohol involvement determined by blood alcohol level

4.00

9.51

3.3

2.5

—

Systemic lupus erythematosus

161

2.85

9.49

2.4

2.5

—

Paracetamol or NSAID medication

187

557

1.70

9.44

2.8

3.1

—

Renal agenesis and other reduction defects of kidney

8.52

9.43

7.4

9.7

—

Thoracic aortic aneurysm

175

1056

1.68

9.43

3.0

2.7

—

Evidence of alcohol involvement determined by level of intoxication

5.07

9.41

2.6

2.9

—

Acute lymphadenitis

261

2.41

9.40

3.1

2.8

—

Psoriasis vulgaris

197

1225

1.62

9.38

3.5

2.8

—

Behavioural disorders, excluding more controls

4.29

9.38

2.6

7.4

—

Event of undetermined intent

324

2.26

9.38

3.1

2.6

—

Abscess of lung

3.58

9.32

4.2

2.4

—

Other inflammatory liver diseases

377

2.16

9.31

3.3

2.6

—

Necrotizing fasciitis

9.85

9.27

5.3

2.5

—

Aspergillosis

4.83

9.21

2.9

2.7

—

Other juvenile arthritis

147

2.90

9.20

3.8

2.9

—

Injury of intra-abdominal organs

126

3.10

9.20

2.2

2.4

—

Secondary thrombocytopenia

4.14

9.17

3.3

2.1

—

Other arterial embolism and thrombosis

176

2.74

9.15

5.4

3.0

—

ILD and respiratory illness in diseases classified elsewhere

7.49

9.14

7.3

2.0

—

Amyloidosis, other/unspecified

3.45

9.14

5.0

2.8

—

Cervical disc disorders

367

2610

1.41

9.13

2.8

2.9

—

Paraplegia, diplegia of upper limbs

127

3.09

9.11

4.6

2.2

—

Monoamine oxidase A inhibitors

117

635

1.86

9.10

3.1

2.7

—

Drug-induced osteoporosis

4.24

9.09

3.0

2.6

—

Other psoriatic arthropathies

110

587

1.90

9.04

2.7

2.8

—

Other abnormal findings of blood chemistry

279

2.34

9.04

2.8

3.0

—

Injury of other and unspecified intrathoracic organs

422

2.07

9.03

2.8

—

Acquired absence of organs, not elsewhere classified

4.08

8.99

4.8

2.6

—

Other immunodeficiencies

4.50

8.98

4.0

3.4

—

Osteonecrosis due to drugs

3.74

8.96

2.4

2.5

—

Septal defects

368

2.14

8.95

4.1

4.9

—

Habit and impulse disorders

4.43

8.92

1.8

2.1

—

Prurigo nodularis

145

2.91

8.90

4.6

2.6

—

Amputation of foot

185

2.68

8.88

4.5

3.0

—

Hyperaldosteronism

162

2.79

8.86

2.5

2.9

—

Tumor necrosis factor alpha inhibitors

139

801

1.75

8.85

2.8

—

Visual disturbances

498

3739

1.34

8.83

2.7

2.9

—

Mental retardation, wide definition

256

2.38

8.77

3.1

5.1

—

Disorders of vitreous body and globe

538

3924

1.32

8.77

3.2

2.8

—

Other arthrosis

543

2841

1.33

8.76

2.5

2.7

—

Hypermetropia

386

2.10

8.75

7.2

3.4

—

Psoriatic arthropathies, ICD10

112

608

1.86

8.74

2.7

2.8

—

Acquired absence of limb

4.58

8.73

4.0

2.5

—

Otitis externa, unspecified

116

637

1.84

8.72

4.5

3.0

—

Other noninfective disorders of lymphatic vessels and lymph nodes

192

2.61

8.72

3.0

2.7

—

Other necrotizing vasculopathies (FG)

361

2.14

8.71

3.5

2.7

—

Nonpyogenic thrombosis of intracranial venous system

4.76

8.70

3.0

2.6

—

4.45

8.65

2.9

1.9

—

Hypermobility syndrome

175

2.66

8.63

2.4

2.7

—

Allergic bronchopulmonary aspergillosis (ABPA)

21.57

8.62

3.4

2.5

—

Pre-eclampsia

143

837

1.72

8.61

2.6

2.4

—

Aneurysms, operations, SAH

177

1097

1.63

8.60

2.9

2.7

—

Papilloedema, unspecified

105

3.23

8.57

2.9

—

malignant neoplasm of male genital organs

365

1580

1.42

8.53

2.7

2.9

—

Spontaneous rupture of synovium and tendon

493

1.95

8.52

3.2

2.7

—

Other surgical follow-up care

121

3.03

8.50

3.4

2.4

—

Malignant neoplasm of colon

169

1039

1.64

8.49

2.6

2.7

—

Corneal ulcer

182

1139

1.61

8.49

3.0

2.9

—

Congenital malformations of the respiratory system

106

3.22

8.48

4.5

6.6

—

Cardiomyopathy, Hypertrophic obstructive

3.65

8.47

5.7

2.6

—

Rare circulating lymphoid malignancy, including Hilmo

166

2.72

8.46

2.7

3.1

—

Pain in thoracic spine

139

812

1.73

8.45

2.7

2.9

—

Bacterial, viral and other infectious agents

467

1.97

8.43

3.6

3.1

—

Cluster headache, strict

127

2.96

8.42

3.4

2.7

—

Mild mental retardation

133

2.93

8.40

3.0

4.0

—

Intracerebral haemorrhage

165

1012

1.65

8.39

3.5

2.8

—

Myopia

113

623

1.83

8.38

2.8

—

Budesonide

120

674

1.79

8.37

3.0

2.5

—

Olecranon bursitis

401

2.05

8.34

3.8

2.9

—

Alcohol abuse counselling and surveillance

3.62

8.33

3.3

2.1

—

Alkalosis

19.43

8.32

4.5

3.0

—

Osteomyelitis of vertebra

11.28

8.31

6.9

3.1

—

Aortic valve malfunction, age under 60 years

101

540

1.89

8.30

3.9

3.5

—

Disorders of vitreous body

519

3820

1.32

8.29

3.2

2.8

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

3.50

8.29

7.0

5.0

—

Hydrocephalus in other diseases

7.36

8.28

3.4

2.4

—

Special screening examination for infectious and parasitic diseases

875

0.44

8.26

3.1

2.2

—

Renal agenesis and other reduction defects of kidney

6.82

8.26

7.4

8.4

—

Dissocial personality disorder

3.79

8.25

2.4

2.1

—

Hodgkin lymphoma, hilmo

140

2.85

8.24

3.4

2.5

—

Injuries involving multiple body regions

204

2.50

8.20

2.7

2.4

—

Osteonecrosis

370

2.09

8.19

3.5

2.8

—

Biological medicines for asthma

3.66

8.19

2.3

2.4

—

Postzoster neuralgia

3.49

8.18

4.5

2.8

—

Chronic sinusitis

409

3016

1.36

8.16

3.1

2.8

—

Early complications of trauma

235

2.38

8.15

3.6

2.6

—

!Aliquae complicationes praecoces traumatis

235

2.38

8.15

3.6

2.6

—

Other Crohn's disease

331

2.14

8.11

3.1

2.5

—

Haemorrhoids and perianal venous thrombosis

334

2383

1.41

8.11

2.9

2.8

—

L04AC Interleukin inhibitors

267

2.28

8.08

2.3

2.6

—

Dislocation, sprain and strain of joints and ligaments of thorax

170

2.64

8.07

3.1

2.7

—

Testicular dysfunction

188

2.55

8.04

3.0

2.7

—

Abnormal blood-pressure reading, without diagnosis

170

2.62

8.04

8.0

2.7

—

Stomatitis and related lesions

191

1226

1.57

8.02

2.9

—

Brachial plexus disorders

413

2.01

8.02

2.4

2.6

—

Congenital malformations of the respiratory system

115

3.05

8.01

4.4

6.2

—

Congenital malformations of trachea and bronchus

4.13

8.01

5.1

4.1

—

FESS (DNB20)

123

706

1.76

8.01

2.5

2.7

—

Ethmoidectomy

127

736

1.74

7.99

2.4

2.7

—

Acquired haemolytic anaemia

137

2.85

7.99

8.2

2.6

—

6.99

7.98

5.1

2.1

—

Glaucoma suspect

389

2862

1.37

7.97

2.9

—

Migraine with aura and triptan purchases

117

662

1.78

7.97

2.3

2.5

—

Malignant neoplasm of colon, including Hilmo

211

1387

1.53

7.95

2.6

2.8

—

Other fall from one level to another

231

1548

1.50

7.94

2.7

3.1

—

Chronic hepatitis, not elsewhere classified

178

2.58

7.89

2.4

2.5

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

4.19

7.89

2.2

2.5

—

Other specified congenital malformation syndromes affecting multiple systems

3.48

7.87

6.0

5.9

—

Coeliac disease

123

710

1.75

7.86

2.9

3.1

—

Oesophageal varices

265

2.27

7.84

4.1

2.7

—

Outcome of delivery

460

0.32

7.81

1.8

2.3

—

Enteropathic arthropathies

106

3.09

7.80

2.5

2.4

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

159

983

1.63

7.79

2.8

2.6

—

Malignant neoplasm of endocrine gland

330

2.12

7.79

2.8

2.9

—

Diseases of inner ear

572

4309

1.29

7.78

2.6

2.8

—

Other and unspecified coagulation defects

240

2.33

7.78

3.3

2.6

—

Other diseases of stomach and duodenum

398

2.01

7.77

4.3

2.8

—

Unspecified visual impairment (binocular)

3.30

7.76

3.5

2.2

—

Atopic dermatitis, strict definition with reimbursement

237

1547

1.49

7.75

2.7

2.9

—

Corns and callosities

399

2.01

7.72

2.8

2.7

—

Sequelae of other external causes

319

2.13

7.68

4.1

2.8

—

Atrophic disorders of skin

132

783

1.70

7.65

2.5

2.7

—

Bell's palsy

120

694

1.75

7.64

3.5

2.8

—

Pre-eclampsia or eclampsia

152

935

1.64

7.63

2.7

2.4

—

Cushing syndrome

4.23

7.62

3.2

2.1

—

Fall on and from stairs and steps

261

1809

1.45

7.60

2.5

2.9

—

Otitis externa

218

1460

1.50

7.56

3.8

2.9

—

Osteopathy in diseases classified elsewhere

4.64

7.55

3.9

3.4

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

153

2.68

7.53

3.3

3.0

—

Multiple myeloma

153

2.68

7.53

3.3

3.0

—

Assault by bodily force

368

2.03

7.53

2.4

—

Congenital malformations and deformations of the musculoskeletal system

421

1.96

7.50

3.3

4.1

—

Toxic effect of corrosive substances

8.92

7.47

3.1

2.4

—

Autism

3.17

7.44

1.4

4.6

—

Malignant neoplasm of prostate

355

1540

1.39

7.42

2.7

2.9

—

Salpingitis and oophoritis

141

858

1.66

7.42

3.4

2.7

—

Caries of dentine, including avohilmo

888

3698

1.23

7.41

2.9

—

Testicular hypofunction

166

2.58

7.40

3.2

2.6

—

Seropositive rheumatoid arthritis, strict definition

149

921

1.63

7.39

2.9

2.8

—

Crohn's disease of small intestine

337

2.07

7.39

3.0

2.7

—

Behavioural syndromes associated with physiological disturbances and physical factors

908

5291

1.22

7.37

2.5

2.8

—

Speech and linguistic disorders

469

1.88

7.36

4.2

4.1

—

Superficial injuries involving multiple body regions

132

2.79

7.34

3.0

2.5

—

Adalimumab

462

1.90

7.33

2.7

—

Other and unspecified immunodeficiencies with predominantly antibody defects

3.95

7.33

5.0

3.4

—

Cardiac murmurs and other cardiac sounds

401

1.96

7.33

4.5

3.2

—

Pleural plaque with presence of asbestos

120

705

1.73

7.33

3.5

2.9

—

Disorders of puberty, all

3.57

7.32

4.0

5.0

—

Mixed specific developmental disorders

116

2.86

7.31

6.5

7.8

—

Ovarian cyst

281

1128

1.44

7.31

2.7

—

Nonhereditary hypogammaglobulinemia

4.44

7.29

5.7

3.0

—

Other and unspecified epidermal thickening

144

2.70

7.29

3.5

2.7

—

Basal cell carcinoma, including avohilmo

464

2430

1.32

7.27

2.8

—

Mantle cell lymphoma

3.95

7.20

2.9

2.4

—

Infection of intervertebral disc (pyogenic)

3.46

7.20

3.7

2.9

—

Carcinoma in situ of other and unspecified sites

289

2.17

7.18

2.9

3.0

—

Spondylolisthesis/Spondylolysis

170

1093

1.57

7.15

2.8

3.0

—

Abnormalities of gait and mobility

146

907

1.63

7.14

2.9

3.3

—

SLE, ICD10

163

2.56

7.14

2.4

2.5

—

SLE, strict definition

163

2.56

7.14

2.4

2.5

—

Polyglandular dysfunction

15.45

7.10

4.4

1.6

—

Artificial joint operation, meniscal resection

990

5342

1.21

7.10

2.5

2.9

—

Congenital malformations and deformations of the musculoskeletal system

543

1.81

7.09

3.2

3.8

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.69

7.07

2.5

2.6

—

Infections of genitourinary tract in pregnancy

370

1.99

7.06

3.0

2.5

—

Diseases of salivary glands

298

2145

1.40

7.04

2.9

2.8

—

Pregnancy hypertension

282

1797

1.41

7.00

2.8

2.5

—

Spondylopathies (FG)

121

719

1.70

7.00

2.1

2.7

—

Congenital iodine-deficiency syndrome/hypothyroidism

159

2.57

6.99

2.8

2.7

—

Fall on same level involving ice and snow

565

4461

1.27

6.98

2.6

2.7

—

Abnormal findings on diagnostic imaging of central nervous system

220

2.31

6.97

2.7

2.5

—

Fracture at wrist and hand level

325

2372

1.37

6.96

2.8

—

Ventricular septal defect, a heart condition

130

2.75

6.96

4.4

6.2

—

3.76

6.95

2.0

2.5

—

Inflammatory disorders of male genital organs, not elsewhere classified

3.66

6.94

2.5

3.4

—

Iridocyclitis

221

1512

1.47

6.93

2.6

2.9

—

Inflammatory diseases of prostate (prostatitis)

153

969

1.60

6.92

3.4

2.9

—

Colorectal adenocarcinoma

215

1461

1.48

6.91

2.7

2.8

—

Assault by sharp object

3.42

6.89

2.7

2.2

—

Generalized skin eruption due to drugs and medicaments

209

2.34

6.88

3.1

2.9

—

IBD patients in KELA-register

205

1384

1.49

6.87

3.7

2.7

—

Secondary malignant neoplasm of respiratory and digestive organs

3.11

6.86

1.8

2.8

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

154

2.57

6.85

5.1

4.7

—

ILD medications: pirfenidone

3.66

6.83

4.7

2.7

—

Myeloproliferative diseases

562

1.78

6.80

2.9

2.8

—

Lack of expected normal physiological development

3.44

6.79

5.1

2.8

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

18.16

6.79

5.8

2.7

—

Malignant neoplasm of prostate, including Hilmo

361

1584

1.36

6.79

2.6

2.9

—

Other bacterial agents as the cause of diseases classified to other chapters

3.41

6.79

5.9

3.0

—

malignant neoplasm of female genital organs

131

797

1.65

6.79

2.7

—

Syphilis

138

2.67

6.78

4.5

2.5

—

Syphilis

138

2.67

6.78

4.5

2.5

—

Superficial injury of ankle and foot

109

636

1.73

6.77

2.8

3.3

—

Acute and subacute iridocyclitis

186

1236

1.52

6.76

2.8

2.9

—

Other aneurysm

399

1.94

6.72

3.9

2.7

—

Menorrhagia

274

1070

1.43

6.71

2.8

2.7

—

Periodontitis

1009

5655

1.20

6.67

2.9

2.8

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

313

1987

1.37

6.66

2.8

2.6

—

Other injuries of spine and trunk, level unspecified

4.32

6.63

3.1

2.3

—

Ingrowing nail

284

2.11

6.62

4.1

2.5

—

Disorders of puberty

3.53

6.62

3.5

2.6

—

Acute nephritic syndrome

117

2.81

6.61

5.2

2.4

—

Haemolytic anaemias

207

2.32

6.59

7.2

2.8

—

Chronic periodontitis, including avohilmo

1005

5654

1.19

6.54

2.9

2.8

—

Unspecified jaundice

306

2.06

6.53

3.9

2.8

—

5.88

6.53

3.2

2.0

—

Disorders of optic nerve and visual pathways

510

1.80

6.52

3.0

2.8

—

Other bursopathies

134

835

1.62

6.50

3.3

2.8

—

Other noninflammatory disorders of uterus, except cervix

190

851

1.51

6.48

2.5

2.8

—

Basal cell carcinoma

444

2363

1.31

6.47

2.8

—

Certain conditions originating in the perinatal period

362

1.90

6.45

6.5

3.4

—

Hydrocele

148

947

1.58

6.44

2.7

3.0

—

Carcinoma in situ of skin of other and unspecified parts of face

114

685

1.69

6.43

3.9

2.8

—

Pilonidal cyst

376

1.93

6.43

2.8

2.5

—

Complications of genitourinary prosthetic devices, implants and grafts

136

2.63

6.43

2.5

2.4

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

9.94

6.42

2.9

1.6

—

Hypertension, Pulmonary Arterial

5.38

6.42

4.3

3.2

—

Cervicalgia

192

1299

1.49

6.41

2.6

2.9

—

Sequelae of injuries, of poisoning and of other consequences of external causes

219

1521

1.45

6.39

2.6

2.9

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.66

6.37

2.1

2.7

—

Membranous nephropathy

6.83

6.35

3.9

1.8

—

Other extrapyramidal and movement disorders in other diseases

241

1706

1.42

6.35

2.6

2.8

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

8.54

6.34

5.4

2.4

—

Other and unspecified psoriasis

407

1.89

6.33

2.6

2.8

—

Dental caries, including avohilmo

834

3516

1.22

6.33

3.1

2.8

—

Anankastic personality disorder

137

2.59

6.30

2.1

—

Other specified/unspecified soft tissue disorders

263

2.12

6.30

3.0

2.5

—

Iron deficiency

3.04

6.25

5.1

2.6

—

Systemic lupus erythematosus, unspecified

144

2.55

6.24

2.3

2.6

—

Endometriosis

265

1105

1.41

6.23

2.7

—

Hypertension, portal

9.41

6.23

3.9

1.6

—

Follow-up examination after treatment for malignant neoplasms

121

744

1.64

6.22

2.9

—

Diseases of pulp and periapical tissues and dental caries

753

3153

1.23

6.22

3.1

2.8

—

Autism spe

2.95

6.19

1.3

5.5

—

Hypersensitivity pneumonitis due to organic dust

3.04

6.19

5.2

2.4

—

Persons encountering health services in circumstances related to reproduction

309

2800

0.74

6.19

3.7

2.9

—

Chronic lymphocytic leukaemia, helper endpoint

163

2.45

6.18

3.1

2.8

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

163

2.45

6.18

3.1

2.8

—

Chronic lymphocytic leukaemia

163

2.45

6.18

3.1

2.8

—

Other misadventures during surgical and medical care

139

2.58

6.18

4.1

2.5

—

Ulcer of oesophagus

483

1.80

6.18

3.8

2.9

—

Intercostal neuropathy

4.29

6.17

2.6

2.3

—

Other epidermal thickening

259

2.12

6.16

3.5

2.8

—

Tracheo-bronchomalasia

13.11

6.15

1.7

1.6

—

Background retinopathy and retinal vascular changes

116

2.74

6.15

4.5

2.4

—

Systemic sclerosis (FG)

2.89

6.14

5.9

2.3

—

Carcinoma in situ, bladder

267

2.11

6.14

2.5

2.9

—

Anterior Iridocyclitis

196

1345

1.47

6.12

2.8

2.9

—

Hyperfunction of pituitary gland

201

2.27

6.10

3.9

2.2

—

Chondropathies

139

888

1.58

6.09

2.9

2.8

—

Accidental poisoning by and exposure to alcohol

3.15

6.09

2.1

—

Ulcerative colitis (strict definition, require KELA)

148

959

1.55

6.09

4.2

2.8

—

Drug-induced interstitial lung disorders, unspecified

16.95

6.08

3.8

2.3

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

3.45

6.07

2.0

2.9

—

Maternal care for other conditions predominantly related to pregnancy

126

771

1.61

6.05

2.0

2.3

—

Chylothorax

10.43

6.01

2.7

1.7

—

Paranoid personality disorder

3.05

6.01

2.6

2.2

—

Malignant neoplasm of rectum, including Hilmo

131

830

1.59

5.97

3.2

2.7

—

Fracture of forearm

517

3770

1.26

5.96

2.7

2.8

—

Inflammatory bowel disease, strict (require KELA)

205

1426

1.45

5.96

3.7

2.7

—

Pre-eclampsia or poor fetal growth

196

1347

1.46

5.94

2.6

2.4

—

Cluster headache, wide,, including avohilmo

236

2.14

5.94

2.9

2.4

—

Car occupant injured in other and unspecified transport accidents

165

1101

1.51

5.93

2.9

2.7

—

Thyroiditis, ILD-related definition

570

1.72

5.93

3.5

2.6

—

Malignant neoplasm of brain, including Hilmo

263

2.08

5.92

2.4

3.7

—

Artrosis, including avohilmo

881

4028

1.20

5.91

2.6

2.9

—

Assault by other specified means

5.52

5.91

2.2

3.0

—

Benign neoplasm of colon, rectum, anus and anal canal

691

4933

1.22

5.89

3.2

2.8

—

Suggestive for eosinophilic asthma

527

1.74

5.88

3.2

2.8

—

Non-small cell lung cancer, squamous

340

1.94

5.86

2.5

2.9

—

Fall involving bed

225

2.18

5.85

3.4

2.6

—

Malignant neoplasm of adrenal gland, including Hilmo

5.12

5.85

3.8

4.8

—

Dental operations

710

2984

1.23

5.85

2.9

2.7

—

Injury of nerves and spinal cord at neck level

131

2.58

5.85

2.4

2.7

—

Specific development disorders of scholastic skills

183

2.29

5.84

4.0

4.9

—

Underdevelopment of the second kidney

15.34

5.84

8.3

2.0

—

Other and unspecified abdominal hernia

265

2.07

5.83

3.4

2.8

—

Secondary parkinsonism+Parkinsonism in other disease

174

2.35

5.82

4.2

2.7

—

Sequelae of intentional self-harm, assault and events of undetermined intent

7.14

5.81

1.8

2.8

—

Secondary parkinsonism

168

2.37

5.81

4.3

2.6

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

258

2.07

5.80

2.9

2.1

—

Pure hyperglyceridaemia

114

2.69

5.78

2.8

—

Colitis, primary sclerosing

3.32

5.78

4.7

2.6

—

Follicular lymphoma, hilmo

273

2.05

5.77

3.0

—

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

14.49

5.75

5.0

4.3

—

Malignant neoplasm of rectum

103

621

1.68

5.75

2.9

2.8

—

Malignant neoplasm of thyroid gland

300

1.99

5.75

2.6

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

3.87

5.74

3.8

2.8

—

Malignant neoplasm of small intestine

109

2.72

5.72

3.4

2.6

—

Other and unspecified nerve root and plexus disorders, also in other diseases

175

1192

1.48

5.71

2.4

2.8

—

Other specified/unspecified bacterial intestinal infections

400

1.85

5.71

3.9

2.7

—

Superficial injury of forearm

532

1.73

5.69

2.4

2.9

—

Acute generalized exanthematous pustulosis

234

2.13

5.68

3.1

2.7

—

Polymyalgia rheumatica

154

1025

1.52

5.66

2.9

2.8

—

Other bacterial agents as the cause of diseases classified to other chapters

3.41

5.66

5.9

3.0

—

Personal history of other diseases and conditions

449

1.79

5.66

4.6

2.4

—

Ulcerative rectosigmoiditis

445

1.79

5.63

2.6

2.8

—

Fracture of neck

424

1.82

5.63

2.9

2.8

—

Reactive arthropathies

460

1.78

5.61

2.7

2.9

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

156

1042

1.51

5.61

4.1

2.8

—

Idiopathic thrombocytopenic purpura

177

2.30

5.60

7.4

3.1

—

Other specific arthropathies, wide

2.78

5.57

3.5

2.3

—

Cluster headache, strict, including avohilmo

216

2.16

5.56

3.0

2.5

—

Diplopia

136

885

1.55

5.55

2.6

2.8

—

Social phobias

297

1.97

5.53

2.2

2.3

—

Squamous cell neoplasms and carcinomas of the skin

103

628

1.66

5.53

2.9

2.6

—

Faecal incontinence

470

1.76

5.51

3.5

2.7

—

Neovascular glaucoma

271

2.03

5.51

2.9

2.7

—

Conduct disorder

2.82

5.50

2.5

5.8

—

Myeloproliferative diseases (CML excluded)

509

1.73

5.47

2.9

2.8

—

Other and unspecified injuries of ankle and foot

198

2.20

5.46

5.2

2.7

—

Spirochaetal infections, other/unspecified

540

0.35

5.46

2.8

3.0

—

Degeneration of the brain due to alcohol

148

2.43

5.46

3.5

2.7

—

Exclusion endpoint for clefts

100

2.76

5.46

6.0

5.4

—

Strabismus

242

1758

1.38

5.45

3.6

3.0

—

Wet age-related macular degeneration

217

1506

1.41

5.45

2.7

2.8

—

Right ventricular outflow tract obstruction

3.87

5.44

6.2

7.4

—

Mixed disorders of conduct and emotions

2.99

5.44

2.5

4.8

—

Myelodysplastic syndrome, including Hilmo

186

2.25

5.43

2.9

2.7

—

Other intracranial haemorrhages

239

2.09

5.42

2.7

—

Malignant neoplasm of bone and articular cartilage

3.67

5.39

2.9

2.4

—

Hypoplasia of dental enamel, prenatal

6.72

5.39

16.7

4.8

—

Subarachnoid haemorrhage

114

718

1.60

5.38

2.8

2.9

—

Lesion of lateral popliteal nerve

294

1.97

5.38

2.7

2.9

—

Somnolence

3.27

5.37

3.6

2.4

—

Congenital malformations of great arteries

128

2.51

5.37

4.7

6.9

—

Diseases of oral cavity, salivary glands and jaws

689

2919

1.22

5.37

2.9

2.7

—

Retinal vascular occlusion

141

933

1.53

5.36

3.3

2.8

—

Lupus nephritis

6.37

5.36

2.5

1.7

—

Retinal vascular disorders

144

958

1.52

5.34

3.3

2.8

—

Other disorders of optic [2nd] nerve and visual pathways

380

1.84

5.33

3.2

2.8

—

Artificial joint re-operation

476

1.75

5.32

2.8

—

Injury of unspecified body region

483

1.74

5.32

3.2

2.8

—

Nail disorders

461

1.75

5.30

3.8

2.6

—

Visual impairment including blindness (binocular or monocular)

454

1.76

5.30

3.4

2.9

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

110

689

1.60

5.29

2.7

2.5

—

Exposure to other specified factors

727

5580

1.20

5.26

3.0

2.8

—

Glaucoma secondary to other eye disorders

276

1.99

5.25

2.9

2.7

—

Malignant neoplasm of corpus uteri

411

1.79

5.24

3.2

2.6

—

Any dementia, excluding more controls

425

2305

1.28

5.23

2.3

2.8

—

Use of trihexyphenidyl

14.96

5.23

6.9

1.3

—

6-mercaptopurine

120

2.53

5.22

2.2

2.6

—

Small fibre neuropathy

183

2.23

5.21

3.3

2.6

—

Malignant neoplasm of corpus uteri, including Hilmo

479

1.73

5.19

3.1

2.7

—

Malignant neoplasm of thyroid gland, including Hilmo

340

1.87

5.18

2.7

—

Wilms' tumor, including Hilmo

3.95

5.18

4.6

3.4

—

Malignant neoplasm of small intestine, including Hilmo

177

2.25

5.18

3.1

2.8

—

Primary open-angle glaucoma, strict

298

2256

1.33

5.17

2.8

2.9

—

Disturbances of skin sensation

225

1635

1.38

5.16

2.3

2.7

—

Herpesviral keratitis and keratoconjunctivitis

257

2.01

5.16

4.0

2.9

—

Erythema nodosum

127

2.48

5.15

3.0

2.5

—

Cystic fibrosis

10.93

5.15

2.6

3.2

—

Anosmia

6.54

5.14

1.9

1.3

—

Viral warts

182

1277

1.43

5.12

4.2

2.8

—

Open wound of neck

3.69

5.11

2.9

2.2

—

Prolonged pregnancy

523

0.40

5.11

1.7

2.5

—

Gonarthrosis,primary

955

5027

1.17

5.10

2.6

2.9

—

Degeneration of nervous system due to alcohol

153

2.35

5.10

3.5

2.7

—

Colitis, primary sclerosing, strict definition

3.66

5.09

3.7

2.9

—

Thyrotropin deficiency

3.66

5.09

4.2

2.8

—

Explicit fungal Sepsis

4.92

5.08

5.9

2.1

—

470

3465

1.25

5.08

3.0

2.8

—

Colon adenocarcinoma

125

816

1.55

5.07

2.5

2.7

—

Burns and corrosions

127

832

1.54

5.06

3.4

3.1

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

137

912

1.51

5.06

4.3

2.8

—

Reactive arthropathies, FINNGEN

365

1.83

5.04

2.6

2.8

—

Degenerative macular diseases

137

914

1.51

5.04

2.6

2.7

—

Urethral stricture

432

1.76

5.03

3.3

2.9

—

Conotruncal defects

2.94

4.98

4.7

7.1

—

Systemic sclerosis,strict definition

3.79

4.98

3.7

2.7

—

Universal erythroderma, KELA reimbursement

2.94

4.98

2.7

1.8

—

Urethritis and urethral syndrome

2.71

4.94

3.0

2.5

—

Kyphosis

3.00

4.93

3.7

2.9

—

Systemic sclerosis

112

2.55

4.91

5.9

2.4

—

Injury of eye and orbit

124

814

1.53

4.90

2.3

3.1

—

Single delivery by forceps and vacuum extractor

399

0.44

4.90

1.6

2.6

—

Other keratitis

101

633

1.61

4.90

2.8

2.7

—

Essential (haemorrhagic) thrombocythaemia

208

2.10

4.88

2.9

2.6

—

Abscess of external ear

3.06

4.88

4.0

2.4

—

Fissure and fistula of anal and rectal regions

216

1576

1.38

4.87

2.9

2.8

—

Endometriosis of rectovaginal septum and vagina

333

1.85

4.86

2.7

2.8

—

Cachexia

5.49

4.86

4.2

2.9

—

Seborrhoeic dermatitis

100

627

1.61

4.86

3.5

3.0

—

Rotator cuff syndrome

616

3659

1.21

4.85

2.7

2.8

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Oxygen saturation in Capillary blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS